Podcasts about Clinical pathology

Want to know more about the application process to become a Veterinary Technician Specialist in Clinical Pathology? Join Kendra, RVT, VTS - EVN and Lori, CVT, VTS - Clin Path as they go over the process step by step. What experience and education is needed to get started on the application? How can one be successful in this process? What types of skills and knowledge base is required to be an advanced technician in clinical pathology? Be sure you stay for the amazing urinalysis tip a the end!

Sheila Wood, an Intuitive Healing Coach with a PhD in Clinical Pathology, holds a distinct space in trauma healing. Her unique fusion of energy healing, mediumship, and Akashic Record insights with her academic alignment create prolific healing environments. Rooted in a mission to heal the generational echoes and lifetime impacts of sexual assault trauma, Sheila's method locates and liberates deeply ingrained, often physically expressed, emotions. Her integrative approach serves those plagued by remnants of harrowing experiences, offering them liberation from embedded traumas and a path to transformative healing. Host: Katie Koestner Editor: Evan Mader Producers: Emily Wang and Catrina Aglubat

Dr. Amir Kol, DVM, PhD, Dipl. ACVP is an Associate Professor in the Department of Pathology, Microbiology, and Immunology at the UC Davis School of Veterinary Medicine. He earned his veterinary degree from the Koret School of Veterinary Medicine in Israel in 2006. Following this, he completed a residency in clinical pathology and a PhD in integrative pathobiology at UC Davis, focusing on stem cell biology and regenerative medicine. Dr. Kol's research centers on translational biomedical science, particularly mesenchymal stem cells, regenerative therapies, and disease modeling. His work leverages naturally occurring diseases in companion animals to inform veterinary and human medicine. He has published over 40 peer-reviewed articles. Another great podcast about FIP!

Welcome to Ask Stago, the Podcast dedicated to provide expert answers to your expert questions in coagulation.  In today's episode, Anne-Cécile Ortega will further explain what a MyOptiLab audit is — a service offered by Stago that involves a comprehensive workflow study using the Lean Six Sigma methodology. This audit is designed to help laboratories enhance their efficiency by identifying areas for improvement and optimizing processes.  Literature sources: Bhat, R., & Wagh, P. (2013). "Application of Six Sigma methodology in clinical diagnostic laboratories: A case study."  International Journal of Scientific and Research Publications*, 3(7), 1-6.   Goh, T. N., & Ang, K. S. (2011). "The application of Lean Six Sigma in healthcare."  International Journal of Quality & Reliability Management*, 28(6), 548-564.   Sundararajan, V., & Sharma, P. (2012). "Lean Six Sigma in the clinical laboratory: Achieving improvement in laboratory processes."  Clinical Laboratory Management Review*, 26(2), 82-89.   Kendall, J., & Jones, D. (2017). "The role of Lean Six Sigma in clinical laboratory testing." American Journal of Clinical Pathology*, 147(3), 298-305.   Sofiya, L., & Mirza, M. (2014). "Enhancing diagnostic laboratory performance through Lean Six Sigma." Journal of Healthcare Engineering*, 2014, Article ID 870376, 10 pages.     Content is scientific and technical in nature. It is intended as an educational tool for laboratory professionals and topics discussed are not intended as recommendations or as commentary on appropriate clinical practice.

Send us a textWhat does the FDA jurisdiction for LDTs mean for the labs? Do they need to worry? How do they need to change the way they operate?In this episode, I talk with Dr. Thomas Nifong, a clinical pathologist and VP of CDX operations at Acrovan Therapeutics, about the recent FDA ruling on laboratory-developed tests (LDTs) issued on May 6th, 2024. We discuss the implications of considering LDTs as medical devices, requiring regulation, and explore the authority of FDA versus CLIA. The conversation also covers historical contexts, practical implications of regulatory changes, and the roles of organizations like CAP, ACLA, and AMP in legal challenges against the FDA. We dive into the differences in requirements between CLIA and FDA, New York's alternative approval route, and potential impacts on lab operations and compliance. Join us for an insightful conversation filled with essential information for those in the field of molecular pathology.00:00 Introduction and Special Guest Announcement00:24 FDA's New Rule on Laboratory Developed Tests (LDTs)01:58 Recording the Podcast: A Casual Lunch Conversation03:47 Understanding FDA's Authority Over Medical Devices08:07 Disputes and Legal Challenges12:03 Practical Implications and Industry Reactions12:47 Understanding FDA's Focus: Safety and Efficacy14:11 The Role of CMS and Medical Necessity14:48 Congressional Involvement and Legal Authority16:06 Impact on Labs and Future LDTs18:33 Quality Systems and Compliance20:16 Modifications and Software Updates21:16 Conclusion and Next StepsSupport the showBecome a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!

Send us a textIn this episode, I had a fascinating conversation with Candice Chu, DVM, PhD, DACVP, about how artificial intelligence (AI) is reshaping veterinary diagnostics and education. Candice, a clinical pathologist and educator at Texas A&M, is using AI tools like ChatGPT to improve efficiency in clinical workflows and academic processes. We explored the practical applications of AI, ethical concerns, and its future impact on veterinary medicine.Key Topics Discussed:[00:00:00] Introduction to AI in Veterinary Education and DiagnosticsI ask Candice how AI is changing veterinary education and diagnostics, and she explains how AI is boosting efficiency in both areas.[00:01:00] Candice's Journey in Veterinary MedicineCandice shares her journey from Taiwan to the U.S., her career in veterinary pathology, and becoming an educator at Texas A&M.[00:05:00] Custom GPT Model for Clinical PathologyCandice describes the development of her custom GPT model for clinical pathology and its role in improving diagnostic efficiency.[00:10:00] AI Tools for Academic and Clinical EfficiencyWe talk about how AI tools reduce repetitive tasks, giving professionals more time for critical thinking and decision-making.[00:14:30] Ethical Concerns When Using AI in Veterinary MedicineCandice emphasizes the ethical responsibility of using AI, highlighting the importance of human judgment in AI-assisted diagnostics.[00:20:00] How Veterinary Students Can Leverage AICandice shares tips on how students can use AI to enhance learning, from simplifying research to generating case questions.[00:29:00] AI's Role in Academic Writing and Veterinary PracticeWe discuss how AI tools streamline academic writing and research, and how AI will continue shaping veterinary practice in the future.[00:39:00] Critical Thinking and AI in Veterinary MedicineCandice and I conclude by discussing how critical thinking and professional responsibility are essential when using AI tools.Candice highlighted the transformative role AI can play in both veterinary education and diagnostics, improving efficiency while requiring responsible use. While AI tools like ChatGPT offer many benefits, the human element—our critical thinking and judgment—remains crucial in ensuring accurate results and ethical practices.This episode provides practical insights on how veterinary professionals, educators, and students can harness AI to streamline workflows and improve diagnostic accuracy. Be sure to listen to the full conversation for actionable tips on integrating AI into your practice!EPISODE RESOURCES:About Dr. Candice Chu (Including her social media and achievements)Candice's PaperUndermind AIYoutube Episode of this EpisodeSupport the showBecome a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!

In this episode of the Integrative Health Podcast, Dr. Jen talks with Dr. Joseph Musto, a clinical laboratory science expert with over 50 years of experience. Dr. Musto discusses biotoxin illness and chronic inflammatory response syndrome (CIRS), explaining the role of MARCoNS testing in Dr. Shoemaker's CIRS protocol and the importance of eradicating these bacteria for recovery. He also shares practical advice for clinicians on treating MARCoNS, mold exposure, and biofilm infections, emphasizing the crucial role of lab testing in managing these complex conditions.  Dr. Joseph Musto is the President and Founder of Microbiology Dx, with over 50 years of experience in clinical laboratory science. A Board-Certified Clinical Laboratory Director, Dr. Musto has published more than 20 papers, co-authored seven patents, and developed key diagnostic methods, including those used in Dr. Shoemaker's protocol for biotoxin illness. He has held academic roles, including Associate Professor of Clinical Pathology, and serves as a consultant and laboratory director for multiple institutions. Dr. Musto's expertise spans clinical pathology, antimicrobial research, and innovative diagnostic testing, making him a leading figure in laboratory medicine. Thank you for listening please subscribe and share!- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -Shop supplements:https://healthybydrjen.shop/CHECK OUT a list of my Favorite products here:https://www.healthybydrjen.com/drjenfavoritesWATCH THIS:https://www.youtube.com/watch?v=2lSyAFy5U4U&list=PLaDiqj0yz1eeCOATXPoUDt8HEJxz1_lfW- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -FOLLOW ME:Instagram :: https://www.instagram.com/integrativedrmom/Facebook :: https://www.facebook.com/pflegmedTik Tok :: https://www.tiktok.com/@integrativedrjenYouTube :: https://www.youtube.com/@integrativedrmom- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -FTC: Some links included in PODCAST Thank you for listening please subscribe and share! - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Shop supplements: https://healthybydrjen.shop/ CHECK OUT a list of my Favorite products here: https://www.healthybydrjen.com/drjenfavorites WATCH THIS:https://www.youtube.com/watch?v=2lSyAFy5U4U&list=PLaDiqj0yz1eeCOATXPoUDt8HEJxz1_lfW - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - FOLLOW ME: Instagram :: https://www.instagram.com/integrativedrmom/ Facebook :: https://www.facebook.com/pflegmed Tik Tok :: https://www.tiktok.com/@integrativedrjen YouTube :: https://www.youtube.com/@integrativedrmom - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - FTC: Some links included in this description might be affiliate links. If you purchase a product through one of them, I will receive a commission (at no additional cost to you). I truly appreciate your support of my channel. Thank you for watching! Video is not spons...

Send us a textDr. Deborah Sesok-Pizzini, MD, MBA, is Chief Medical Officer And Senior Vice President, Labcorp Diagnostics, and Global Head of Quality And Discipline Director, Immunohematology, Labcorp ( https://www.labcorp.com/deborah-sesok-pizzini-md-mba ), where she is involved in furthering the company's initiatives to enhance the patient experience, enable health provider decisions and develop innovative testing solutions.Dr. Sesok-Pizzini joined Labcorp with over two decades of experience in healthcare, holding multiple appointments with The Children's Hospital of Philadelphia, including Patient Safety Officer, Chief of the Division of Transfusion Medicine and Vice-Chief of Pathology and Laboratory Medicine. She was also a professor of clinical pathology and laboratory medicine at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, PA.Dr. Sesok-Pizzini earned her medical degree from the Penn State College of Medicine and did her residency and fellowship at The University of Pennsylvania's Perelman School of Medicine. She also graduated from Villanova University, with a Master of Business Administration degree with a concentration in finance.Dr. Sesok-Pizzini holds certifications in clinical pathology and blood bank and transfusion medicine. She is a member of the College of American Pathology, the American Society of Clinical Pathology, and the Association for the Advancement of Blood and Biotherapies. She is a board member of the Intersociety Council for Pathology Information and serves as an adjunct professor with the University of Pennsylvania's Perelman School of Medicine.#DeborahSesokPizzini #ChiefMedicalOfficer #Labcorp #Diagnostics #Immunohematology #ChildrensHospitalOfPhiladelphia #CHOP  #TransfusionMedicine #Pathology #LaboratoryMedicine #PerelmanSchoolOfMedicine #UniversityOfPennsylvania #Penn #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the Show.

In this episode of SEE HEAR FEEL, Christine J. Ko welcomes Dr. Gregory A. Hosler, president of the Dermatopathology Division of Sonic Healthcare USA. The conversation delves into his recent study on diagnostic discordance in dermatopathology, exploring its implications for patient management and highlighting the importance of ancillary testing and second opinions. Dr. Hosler also shares insights on emotional intelligence, emphasizing the significance of self-awareness and continuous improvement in pathology practice.00:00 Introduction and Guest Background01:54 Personal Anecdote and Career Journey02:31 New Role and Responsibilities03:38 Diagnostic Discordance Study07:20 Improving Diagnostic Practices10:55 Emotional Intelligence and Self-Reflection12:42 Final Thoughts and ConclusionGregory A. Hosler, MD, PhD is President of the Dermatopathology Division of Sonic Healthcare USA (SHUSA). Before taking this role, he was at ProPath, which joined SHUSA in 2021, and at ProPath, he served as partner, board member, and Director of Dermatopathology. He is a Clinical Professor in the Departments of Dermatology and Pathology at the University of Texas Southwestern (UTSW). He has held numerous leadership roles in local and national societies, including serving on the Executive Board for the American Society of Dermatopathology (ASDP, 2021-present), as President of the Texas Society of Pathologists (2019), President of the North Texas Society of Pathologists (2015), and President of the Educational Foundation of the TSP (2020).Dr. Hosler obtained his B.S.E. in Chemical Engineering at Princeton University and completed his medical degree and graduate work at UTSW in Molecular and Cellular Biology and Immunology (MD/PhD Medical Scientist Training Program). He completed his residency in Anatomic and Clinical Pathology at The Johns Hopkins Medical Institutions (JHMI), and his fellowship in dermatopathology, also at JHMI. Dr. Hosler is very involved in education, teaching at the fellowship, residency, and medical school levels. He is the Director of the ACGME-accredited Dermatopathology Fellowship Program at ProPath. He actively speaks, writes, and directs courses on dermatopathology. He is the editor and co-author of two dermatopathology textbooks - Molecular Diagnostics in Dermatology: practical applications of molecular testing for the diagnosis and management of the dermatology patient (Springer) and Diagnostic dermatopathology: a guide to ancillary tests beyond the H&E (JP Medical Publishers). He is also the author of the melanocytic chapter in Weedon's Skin Pathology (4th, 5th, and 6th Eds, Elsevier) and many peer-reviewed journal articles and reviews.

Dr. Shoreh Ershadi is the founder of ANITAGING Institute of California and a renowned expert in clinical biochemistry and pharmacology with over 40 years of experience. Dr. Ershadi shares her compelling journey from Iran to the United States, highlighting her unexpected entry into medical technology and the numerous challenges she faced as a woman in science. From setting up clinical labs and pioneering AIDS testing to founding her own antiaging company, Dr. Ershadi discusses her relentless pursuit of scientific innovation and passion for improving human health. The conversation also touches on her entrepreneurial ventures, the role of art in her life, and her vision for a healthier future driven by natural apoptosis-promoting supplements. Guest links: www.Apoptosis.us | www.facebook.com/apoptosisnutraceuticals | www.instagram.com/apoptosisnutraceuticals | www.threads.com/apoptosisnutraceuticals  Charity supported: Save the Children Interested in being a guest on the show or have feedback to share? Email us at podcast@velentium.com.  PRODUCTION CREDITS Host: Lindsey Dinneen Editing: Marketing Wise Producer: Velentium   EPISODE TRANSCRIPT Episode 037 - Dr. Shoreh Ershadi [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello, and welcome back to another episode of The Leading Difference podcast. I'm your host, Lindsey, and today I'm so excited to introduce you to my guest, Dr. Shoreh Ershadi. With over 40 years of expertise in clinical biochemistry and pharmacology, Dr. Ershadi stands at the forefront of scientific innovation in the field of nutraceuticals and supplements. Board certified by the American Academy of Antiaging Medicine and holding dual doctorate degrees, Dr. Ershadi brings a wealth of knowledge and experience to the world. Dr. Ershadi's distinguished credentials, including National Registry in Clinical Chemistry and Toxicology and American Society of Clinical Pathology certifications, underscore her dedication to precision and quality in laboratory practices. Her visionary leadership and unwavering passion for advancing human health has made her a trusted authority in the field. All right. Well, Shoreh, thank you so much for being here today. I'm so excited to speak with you. [00:01:51] Dr. Shoreh Ershadi: Thank you for having me. I'm very excited to talk to you, especially that you're going to talk about medical technology. And that is something that I have been doing or working at for, I would say over 30 years, easy. 1988, I got my license in California. So it's what, 32 years? [00:02:17] Lindsey Dinneen: Yeah. Excellent. Oh my goodness. Well, this leads perfectly into my first question and that is, can you tell us a little bit about yourself and your background and how you got into medtech? [00:02:29] Dr. Shoreh Ershadi: Okay. That is interesting because I was born in Iran and I studied pharmacology. And before I was graduated, the Department of Health in Iran was hiring pharmacists, pharmacologists. So we all went and took the exam and we passed the exam. We were still at the final stages of doing the thesis and going through final stages of graduation. And then they called me and a few other people for an interview. Apparently I had a high mark in the test, which I did not know. So when we went for the interview, and I went to an American school and then later to a British school in Iran, so I was speaking English. At the interview, there was a gentleman who was back in Iran from United States, and he was a PhD in clinical biochemistry, and he asked me to read something in English. And I read it, and he thought that I had it by heart or something, so he flipped the book and found a more difficult page and said, "Okay, read this," and I read that, and he said, "Okay, I'm hiring you for the reference lab." I had absolutely no clue what he was talking about, what was reference lab. I had no intention to even work for Department of Health because I was not even graduated at that time. And then they said, "Okay, start on such and such date." And when I went there the first day, he said he spoke in English and he said, "You're overqualified." Oh my God. What? I mean, it was funny. Without even planning to get into laboratory, I got into the reference lab of Department of Health. And what he was planning to do was to bring College of American Pathologists, the proficiency testing to all the laboratories in Iran. And he wanted someone who would speak English and who could communicate. So first day of my job, I wrote a letter to College of American Pathologists and I said, "Hi, hello, I'm Shoreh Ershadi, I want to buy a thousand proficiency kits." And of course they responded. So just like that, I got into clinical laboratory. And I became the Director of the Quality Control for Department of Health. And that was before the revolution. So, that was my exciting start into laboratory. [00:05:25] Lindsey Dinneen: Yeah, that's an incredible story. Thank you for sharing that. And [00:05:28] Dr. Shoreh Ershadi: Not voluntarily, but serendipitously, yes. [00:05:34] Lindsey Dinneen: There you go. So then at some point, you came to the U. S. and was that transition really difficult? Was it frustrating? Were you excited? Nervous? [00:05:47] Dr. Shoreh Ershadi: There was a part in between before coming to U. S. There was another test by W. H. O., World Health Organization. So I took that test and I passed that test and I got a scholarship to go to medical school in England to do a master's degree. And when I went there, I told them, "I already have a doctorate in pharmacology. I don't want master's. I want to do PhD." And after a few weeks, they said, "Okay, fine, go to PhD. You don't need to do master." So I was in England for about four years. I did my PhD in clinical biochemistry. And I went back to Iran. That was exactly during the revolution. So while I was studying in England, the country in Iran was on fire. It was, things going crazy everywhere. But I went back and I got married. I had my son in Iran, and I was working in a clinical laboratory in one of the best hospitals in Iran, and it got very difficult for women to work. They were saying, " Now you have to wear a scarf. Now, you can't see male patients, you can only talk to female patients." It was not right. So, 1984, I came to United States, I came to California, and with some friends in Iran who had a clinical laboratory, and they were here before me and had started a lab in Orange County, California. I started a branch of the lab in Westwood, in Los Angeles. So that was my first job or position and that was my entrepreneurial side, which now I wouldn't dare to start a life, but then I did. [00:07:51] Lindsey Dinneen: You didn't know the difference then. [00:07:53] Dr. Shoreh Ershadi: Well, yes, I didn't know. I mean, it was a lot easier, I would say. At that point. The lab was not even accepting Medicare or Medi Cal. It was private insurance. I was doing the billing. I was getting the information. I was drawing the patients. I was separating the samples and sending them to the reference lab that was actually running the tests. But I was doing stat CBCs and I was in a medical building and so all the doctors were so nice to send the samples down to me. It worked. So [00:08:33] Lindsey Dinneen: Amazing. Oh my. [00:08:34] Dr. Shoreh Ershadi: Amazing. Yes. Now it sounds really amazing. It's surreal in a way. Yeah. [00:08:42] Lindsey Dinneen: Yeah. Yeah. Well, so, so with that lab and embracing this entrepreneurial journey, and I'm so thankful it worked out so well for you, but were there any moments where you just thought, okay, I've, I, you have such an amazing background. You're so highly educated, you're brilliant. And then you're starting this entrepreneurial journey, which is kind of a different skill set in a way. How was that transition of becoming kind of your own boss and being in charge of everything? [00:09:12] Dr. Shoreh Ershadi: That was pure ignorance. I mean, now I can say then, I thought I knew what I was doing, but it was a fast learning. First that I was in a different country, that I had never been in the United States. Second, that I had a three year old son that I brought with me and my then husband never came, so I got a divorce and I became a single mom. So, and nobody else was from my family was here. So it was very difficult because I had to take him to daycare and then come work and then go pick him up. And then there was a war, the Iraq war had started in Iran and my parents were in Iran and I was going through a divorce, so it was turmoil. And I had to work and learn in a way it was good because it didn't give me time to think about anything else. It was just forward, no looking sideways, no looking backwards. It was just moving forward. But then again, something else happened that made it even more interesting. One of the days that I was at the lab, some guy came and said, "CDL, Central Diagnostic Lab, is looking for a technical director and they've asked me to come and talk to you." I had absolutely no clue if anyone knew me or knew of me or it was the, I mean, a lot of things happened, which, I mean, I'm happy now, but then it changed my life tremendously. And I don't think I've ever talked to anyone about this in this detail. So, Lindsey, I would say you're the first person I'm telling the story of my life. But anyways, I went for an interview and I got hired right away. I had the lab, so I hired someone to do the work that I was doing in the lab. And then I started working at CDL, Central Diagnostic Labs, which was the largest privately owned lab in the United States at that time. There were 1, 200 employees. So that was a very interesting experience on its own because I was introduced to a world that I did not even know what was going on. So, and that was during AIDS testing. Bio-Rad had just come up with Western blot testing and we did the clinical trial, which was very easy in those days. We had AIDS patients and we had a lot of AIDS samples accumulated or saved frozen and we used them to validate the Western blot by Bio-Rad and I went on National TV 1988 and I said, "CDL is the first lab in the world that is doing a confirmation for HIV AIDS testing." So then, that was major. [00:12:40] Lindsey Dinneen: Yes. [00:12:43] Dr. Shoreh Ershadi: But then, then my family came. My father passed away here. It was, again, a lot of complications going on. And one of the other people that I knew asked me to go and partner with them in a lab. Again, my entrepreneurial part took over and I went for the partnership, and I started from scratch. I started Path Labs practically from scratch. There were two pathologists working with Los Alamitos Hospital, and I went there and I started a lab from just buying test tubes, buying, from absolutely nothing. I was there for six years, I think. six or eight years with Path Labs. That was not so successful. After that, I went to Specialty Labs, which is now Quest. Specialty wanted to start a toxicology lab. So, Path Lab was sold. But there was no money made with the partnership and all that. So that was not a very successful six, eight years of my life. Specialty was good. I went to Specialty and I started Department of Toxicology. I don't know if you remember or you were familiar with specialty. Dr. Peters was there and he was the founder, James Peters. He did only immunology testing. They would receive samples and send out everything else to other labs and only do the immunological tests or some specialty tests. When I started the toxicology department, we started getting samples from all over the world. We were running heavy metals and all that. We had an ICP MS and I started running ICP, and the main test that I developed there was measuring iron in the liver biopsy of patients with hemochromatosis. So we would get one spot, in tip of the needle of the liver and then do a measurement and measure the amount of toxicity with iron in hemochromatosis, which was great. I wrote a paper and we were working with Mayo Clinic and they developed the test. So that was very exciting. Then I started the automated lab because all the chemistry. And all the hematology was going out, was sent out. So that brought a lot of money into the lab, but that was not my lab. It was Dr. Peter's lab. It was wonderful. It was nice. But he was the entrepreneur there. So in the year 2000, I started ANTIAGING Institute of California. After passing the specialist chemist license in California, I got National Registry in Certified Chemistry, Certified Toxicology, and then I took the board exam with American Academy of Antiaging Medicine. And that was again entrepreneurial and I started the company, that would be 25 years ago. I've done a lot of consultation. I've been director of lab during COVID. I went back to city health. And I was Director of City Health running 4, 000 COVID patients a night for airports, for schools, for traveling, for a lot of stuff. And then I worked with Siemens Healthineers on regulations for IVDR. So all the kits that Siemens had, over 700 reagent kits that were sold to the laboratories, they need to get the CE mark to be able to be sold in Europe under the new IVDR regulations. And a lot of it had to go through FDA as well because FDA had to approve if there were any changes made to the kits. So I've done a lot of regulation works. I've done a lot of hands on COVID tests, covered it all. Actually, something else that was very interesting. And this, for MedTechs, I would think this would be interesting to know that it's not just one position. And there's so much you can do, if you want to expand your horizon. For about a year, I helped set up extremely high complex laboratory for testing mother's milk, for making milk bank from mother's milk for NICU for children who were born early and the formulas did not work with them. Some of them were so tiny, less than a pound. And so mother's milk bank, it's called Prolacta Bioscience, the company. And I worked there to establish the clinical lab and to get a license for clear and stuff like that. So. [00:18:21] Lindsey Dinneen: Oh! [00:18:21] Dr. Shoreh Ershadi: A lot of good work going into my up and down career, I would say. [00:18:28] Lindsey Dinneen: I love it. Well, first of all, I'm so honored that you were willing to share so much with me. That is. I really appreciate it. And I really appreciate you being willing to talk about some of the amazing moments you've had and the really high, " Yay, we did this," but also some of the moments where it was a little bit tougher and even you being honest and transparent about, the one company didn't do as well as you would have hoped, but you kept going and you are a living testament to resilience and adaptation. [00:18:59] Dr. Shoreh Ershadi: There is no other choice. I would hope that people would have many choices. I mean, you always make choices in life. Even now, this is a choice to talk to you and I appreciate the opportunity because, if I would choose or if I wouldn't know about you, that would be a totally different episode in my life. So I'm open to take chances. You can say that with my experience, living in three different continents and moving and just leaving Iran and coming to us with a three year old, not being here ever before. And then, just jumping in and, but there was no other choice except for moving forward, or we can say, except for success. Because failure was not an option. What would I do? There was nowhere to go back. Sometimes you may have an option to make a U turn and say, "Okay, I don't like this. I want to do something else. I want to stay home." There was no option, no going back. So it was only forward. [00:20:09] Lindsey Dinneen: Yes, absolutely. So, coming here and like you said, having to move forward and I appreciated what you said, you kind of, you couldn't look to the side, you couldn't look back. You had to keep moving forward. How did you go about building a community that could support you, that you could be friends with, and colleagues with, and feel supported coming in from, not having that. [00:20:36] Dr. Shoreh Ershadi: And that was not very difficult. There were many difficult times during that, that I mean, I don't mind talking about it, being a woman, being a young woman, being from a different background there was a lot of resistance. And I see that today as well. I mean, I can't say, "Oh, here I'm in L. A. and Los Angeles is so easy." It's not. I am hoping that women would not maybe experience all the difficulties that I went through. But we're talking about 40 years ago. I came to The States actually July 22nd would be exactly 40 years. I left Iran July 1st, 1984. So this is the 40th anniversary. Being a woman, I thought, when I went to England one of the first things, the professor was my direct supervisor when I worked with him. And I know you can see my face. This is 40 years later. I have no claims, but the professor told me, "You're a beautiful woman. Why do you want to study? Why are you here for PhD?" And I thought that was the greatest insult in my life. So I fought with that professor for four years. [00:22:15] Lindsey Dinneen: No, I'm sorry. [00:22:17] Dr. Shoreh Ershadi: That wasn't easy, but it was so difficult to prove that I am not just a woman or a pretty girl or a young girl or a young woman, or. That was a major fight. I would say that was as difficult as fighting the revolution in Iran, because you wouldn't expect a British professor to say that to you. And I was the only girl, a PhD student, all the others were guys, and this was medical school. And to me, that was very surprising because when I went to University of Tehran, we had probably more girls than guys in the class. Girls were very prone to education in Iran, and they still are. There's still, I think, 60, 65 percent girls in universities, even here. But to hear that was very difficult. That experience repeated itself. in United States over and over till today that I can say I don't feel old. I'm antiaging, but now that I'm an old woman, I still feel that I have to prove myself that I am equal. And sometimes I would say I'm better, but, just to be honest and modest, you want to be treated equal. And that is very difficult. [00:23:53] Lindsey Dinneen: Yeah. Yeah, you're absolutely right. And As much as I would wish things were improving rapidly, I'm not so sure that they are, but what have you found has been helpful in terms of, helping people understand who might come with a bias, but who, helping those people understand, "No I have this education. I am very capable." What are some strategies that you have found that have worked really well for you? [00:24:22] Dr. Shoreh Ershadi: Not many. I have to be honest with you. I mean, if there are a few people, few women, a few even men who are, would be following the conversation, I want them to know that this is not easy. And maybe a part of my success is that I'm a fighter. And I didn't surrender, but I didn't smile my way up. I fought with everyone that went in that direction. And I don't want to get into details, but many of the stronger men would think that if they flirt with you, if they take you out, if they buy dinner for you, then you're going to do what they say. And my story is, just, I have my guards up and I fought. I wouldn't recommend people to fight. Maybe they can find a better solution. I did not find many. Maybe the reason of working separate and starting my own company, maybe one of the major reasons was that I would not have to say yes to power that I did not want to say yes. I worked very hard. I worked hard, long hours. Medtechs, you have to stay there to get the results out. One Christmas. I stayed from December 24th for I would say 72 hours in the lab, maybe two, three hours shower and sleep and go back because we had a lot of toxicology tests that were waiting and results had to go out. And the probe in the I-C-P-M-S was broken. There was no one to replace it during Christmas. It was, we had to borrow from somewhere, FedEx shipping it. Those things happen, you know that, and you have to work hard. It wasn't an easy journey to say, "Oh, I worked four hours a day." And they said, "Thank you. You're so good. Go home." It wasn't like that. [00:26:44] Lindsey Dinneen: Right. Right. Yeah. Well, thank you. I appreciate you sharing that. And so one thing that was really interesting to me, I was looking at your LinkedIn profile and I see that art is a big part of your life in addition to the science and I saw you listed painting and sculpting and I'm wondering how-- well a couple of things-- how did you first get involved in art? And secondly, do you feel that is helpful in terms of having a sort of therapeutic thing to do that kind of maybe helps with some of those harder moments where it's a little frustrating? [00:27:23] Dr. Shoreh Ershadi: Very helpful. But I was as a kid, I started painting at a very young age. And I was always coloring and painting and making things and all that. And my father, a very educated father, he had two master's degree from a University of Texas and came back to Iran. And that's why, we spoke English and we went to English school. So my father was educated and open minded, I can say. But he always said that "You should study art. And don't go to medicine, you'll get old." He passed away in 1988, and I always, when I started Antiaging, I always said "Okay, if you're looking, you will see that I'm antiaging, I didn't age, I went to medical school, I did all the studies." But my logic, first that I love to do this, I mean, it wasn't just you know, forcing myself. I love science. And to this day I do a lot of research. I play with science. You can see the labels are all fancy. I do the paintings. I do all of that. But my logic, more than being scientific, was that this was a career and art would not be a self supporting career, even at younger age. But I always said that if I was a doctor, I could paint, but if I was an artist, I could not do the scientific part or the medical part that I was interested in. But after the divorce, I was in a relationship for 14 years. And I was working hard, raising a son, being a single mother and all that. When that relationship ended after 14 years, the art just popped out. I started painting, sculpting. It was not under control. You can see that, things happen to me, things come out in a certain period. Maybe, I push them down, force them to stay within me, and then they just pop out in different directions. So art came out itself. But there was a period in between that there was no art. Maybe there was too much stress. Maybe there was a lot of, and right now there's no art. Right now it's more entrepreneurial, starting, scientific, all that. But the art pops out every now and then. [00:30:07] Lindsey Dinneen: That's great. Yeah. So speaking of, what you're doing now, I was wondering if you could share a little bit about your company and maybe what you're excited about for its future as you continue along this path. [00:30:19] Dr. Shoreh Ershadi: Okay. That is, this is now where all the passion is. So everything that I have forced inside for all my life is now just coming out into Apoptosis. Apoptosis is a Greek word and it means "falling of the leaves." In science apoptosis, if you Google it, you'll see it means "programmed cell death." So in our bodies in creation or creator or whichever you wanna put it, and I'm sure being a medtech and all the audience, they know there are thousands of reactions inside the body are happening for me just to sit here and breathe and talk. There are thousands and thousands of enzymes and catalysts and metals and oh, whatever is going on. Programmed cell death or apoptosis is a main part of survival. So it's the future of antiaging because we all-- first of all that life expectancy is much longer now. Longevity is longer and younger people do not want to get old. So, at some point I would say my grandmother's generation and my mother is now 95 years old and she's, thank God, healthy and walking and all that, but even she does not want to get old. So, the image of being old and sick is combined together. But we can age without being sick, without getting Alzheimer's, without losing our memory, without getting all these different kinds of diseases. And one major problem is cancer that was much higher with older people and now the statistic is showing that cancer is happening in younger and younger generations. So what apoptosis does is that it's a program in the body. I did not make it. I wish I did, but it's happening all the time. And apoptosis is getting rid of cancer cells, getting rid of damaged cells, getting rid of neurons that cannot connect and synapses with other neurons to take the message over. So if we encourage apoptosis, then all the damaged cells are removed just like falling leaves. They're removed from the body and they're replaced with new energized healthy new cells. Every 10 years, our entire body is regenerated. So why do we get old? We should always stay at a 10 year age. So at 20 years old, we have recycled cells that even though we're growing, growth and youth is defined as between 20 to 25. From 25 to 30, it's sort of stable. There's a plateau. After 30, we start the aging process. So now, as 30 to 60, is still considered not so deep slip going down. It's sort of a plateau up to 60. And then after 60, 70, 80, 90, people are beginning to age. And it shows, I mean, with different diseases, with wrinkles, with memory loss, with all that. So what I'm doing, I'm using nature's product, plant based products, and this has been proven in science that these plants support apoptosis. So, as we get older, just like all the other reactions, apoptosis does not happen at its ultimate way that it should happen. But if we encourage it, for example, we have here, this one is brain beet. This is all beet roots, and it's an organic product. It's all plant based, but it releases nitric oxide. And it works the same way that Viagra works, but it opens all the arteries, it opens the circulation to the brain, to the heart, so why not use it? Why not promote apoptosis the way nature has programmed it in our body, just help it to work better. So that is all my passion right now. [00:35:28] Lindsey Dinneen: Excellent. Excellent. Well, I love that. Thank you for sharing a little bit about it. I'm excited for our listeners to go and learn more about it and, see how they can maybe also take part in the antiaging movement. [00:35:41] Dr. Shoreh Ershadi: Yes, they can partner with us and I would be thrilled. Actually, this is something that maybe I have learned during the long life experience, is that the more partners you have, the more friends you have, the more you share your knowledge, the better it is. Because at some point, it was like people wanted to keep everything to themselves and they didn't want to share or, but right now it's totally different. If they go to Apoptosis.us, they can go to the science section, they can read the papers. And if they would like to partner, I'll be thrilled to work with as many people as possible and take the message out. Yeah, this is a healthy message. This is something that we should all be talking about. [00:36:36] Lindsey Dinneen: Indeed, we should. Yes. Thank you. Well, pivoting the conversation just for fun, imagine that you were to be offered a million dollars to teach a master class on anything you want. It can be in your industry, but it doesn't have to be. What would you choose to teach? [00:36:56] Dr. Shoreh Ershadi: Well, the million dollar would be great. [00:36:59] Lindsey Dinneen: Indeed. [00:37:00] Dr. Shoreh Ershadi: Yes. Yeah. Would we all want that. But yes, I think that right now, as I said, I would use the million dollars to talk about apoptosis all over because I see even young children, every time I see St. Jude's children, and thank you for your donation to Save the Children. I admire that. And I'm hoping that all the children in the world would have a good, healthy future. The world is crazy. You can look at it right now and see that, I can say my experience has been crazy. It doesn't get any better. It's always up and down. Things are happening all over everywhere in the world. And I would like to talk about health, talk about antiaging, talk about Apoptosis and educate more and more of the young people to learn and to avoid all the toxins that we are creating and we have created, with what we're doing with industry and go back to a plant based life, go back to nature, enjoy nature, go back to art, if possible, all the good things that we can do with our lives. [00:38:21] Lindsey Dinneen: Yes, absolutely. And then, how do you wish to be remembered after you leave this world? [00:38:29] Dr. Shoreh Ershadi: Oh, wow. That's a very difficult... a fighter? Survivor? Yep. Strong women? I would support women all the way. Now in Iran, they're saying, Woman Life Freedom. I'm sure you've heard about that. And I cannot tolerate, to see women covered all over with a window to see outside. To me, that is very disturbing. So I would like to see equal opportunity for women and I would like to maybe be remembered as a survivor. [00:39:14] Lindsey Dinneen: Yes, absolutely. And then, final question, what is one thing that makes you smile every time you see or think about it? [00:39:24] Dr. Shoreh Ershadi: Oh, my granddaughter and my grandson. Yes, I have a five year old granddaughter. Her name is Julia and she is my sunshine. She is my life. The grandson is three months old. He's still too young, but he's getting there. [00:39:45] Lindsey Dinneen: Aw! [00:39:48] Dr. Shoreh Ershadi: Getting emotional. [00:39:51] Lindsey Dinneen: I'm so glad. It's that's beautiful. That's wonderful. [00:39:56] Dr. Shoreh Ershadi: Yes, that is continuation of the fight. That is when you see that what you've done is worth the fight, worth the hard work. [00:40:08] Lindsey Dinneen: Absolutely. Absolutely. Yes. Well, this has been amazing. I so appreciate you telling your story and sharing some of it that maybe you haven't done before, and that's I feel very honored. [00:40:23] Dr. Shoreh Ershadi: Yes. [00:40:24] Lindsey Dinneen: Thank you. Thank you for trusting me. [00:40:28] Dr. Shoreh Ershadi: Well, thank you for bringing all of this out. This has been sitting there suffocating, maybe. [00:40:36] Lindsey Dinneen: Yeah. [00:40:37] Dr. Shoreh Ershadi: Thank you. [00:40:38] Lindsey Dinneen: Absolutely. And we are so honored, you mentioned this, but to be making a donation on your behalf as a thank you for your time today to Save the Children, which works to end the cycle of poverty by ensuring communities have the resources to provide children with a healthy, educational, and safe environment. So thank you for choosing that organization to support. And we just wish you the most continued success as you work to change lives for a better world. [00:41:06] Dr. Shoreh Ershadi: Thank you so much, and thank you for having me, and thank you for making me tell the story. Thank you, Lindsey. [00:41:15] Lindsey Dinneen: Of course. And thank you also so much to our listeners for tuning in. And if you're feeling as inspired as I am right now, I would love if you would share this episode with a colleague or two, and we'll catch you next time. [00:41:29] Ben Trombold: The Leading Difference is brought to you by Velentium. Velentium is a full-service CDMO with 100% in-house capability to design, develop, and manufacture medical devices from class two wearables to class three active implantable medical devices. Velentium specializes in active implantables, leads, programmers, and accessories across a wide range of indications, such as neuromodulation, deep brain stimulation, cardiac management, and diabetes management. Velentium's core competencies include electrical, firmware, and mechanical design, mobile apps, embedded cybersecurity, human factors and usability, automated test systems, systems engineering, and contract manufacturing. Velentium works with clients worldwide, from startups seeking funding to established Fortune 100 companies. Visit velentium.com to explore your next step in medical device development.

New opportunities are emerging for dedicated biomarker testing navigators facilitated by laboratory professionals to better streamline sample collection and optimize test ordering and results for patients with cancer. In this episode, CANCER BUZZ TV speaks with Lynnette Pineault, MBA, SCT (ASCP), chair of the American Society for Clinical Pathology (ASCP) Biomarker Testing Navigation Feasibility Study and manager of Laboratory Operations and Genetic Counseling Services, Medical Library and Pathology Services, at HealthPartners – Regions Hospital, who shares insights on reshaping multidisciplinary cancer care team workflows to enable laboratory professionals to improve biomarker testing efficiency. “We see these roles [dedicated biomarker testing navigators] playing across and matrixing to support the sample [biomarker testing specimen] along its pathway, so the patient and the sample get to their destination and their treatment/follow-up at the appropriate times together.”—Lynnette Pineault, MBA, SCT (ASCP) Lynnette Pineault, MBA, SCT (ASCP) Chair, ASCP Biomarker Testing Navigation Feasibility StudyManager, Laboratory Operations and Genetic Counseling Services Laboratory Medicine and Pathology Services HealthPartners – Regions Hospital St. Paul, MN   This video podcast was produced in partnership with the American Society for Clinical Pathology and by support from Amgen, AstraZeneca, Bristol Myers Squibb, Eli Lilly, Exact Sciences, and Merck.    Resources: ASCP Explores Innovative Cancer Biomarker Testing Navigator Role (criticalvalues.org) ACCC Cancer Diagnostics Education Program Precision Medicine Stewardship (accc-cancer.org)  

Transcript with time code:  https://cuttingedgehealth.com/wp-content/uploads/2024/07/Transcript-39-Dr-Russell-Jaffe.pdf In this podcast, Dr. Russell Jaffe discusses affordable strategies for preventing cognitive decline and enhancing overall health. With a background in pathology and internal medicine, he shares insights on the importance of diet, hydration, and lifestyle choices. Dr. Jaffe emphasizes the benefits of whole foods, magnesium, and alkaline diets, alongside practical self-assessments for better health. He also highlights the significance of maintaining a healthy immune system and reducing exposure to harmful chemicals. Discover why Alzheimer's is now considered Type 3 diabetes. As a renowned expert in functional medicine, Dr. Jaffe explains the critical connection between Hemoglobin A1C (HbA1c) levels and cognitive health. Learn why maintaining an HbA1c level of 5 or lower is essential and explore the dietary changes that can help achieve this target. This interview offers valuable, actionable advice for staying mentally vibrant as we age.   *****   About Dr. Russell Jaffe Russell Jaffe, MD, PhD., CCN (DrJ) has more than 40 years of experience contributing to molecular biology and clinical diagnostics. He pioneered “lymphocyte tests of immune function and hypersensitivity” and is focused on providing functional, predictive tests and procedures designed to improve the precision of both diagnosis and of treatment outcomes. He received his B.S., M.D., and Ph.D. from the Boston University School of Medicine and is board certified in Clinical Pathology and in Chemical Pathology.  After being on the permanent senior staff at the National Institutes of Health, he pursued other interests, including starting the Health Studies Collegium think tank. He is Founder and Chairman of PERQUE Integrative Health, LLC, a company that offers the world scientifically proven, integrative health solutions that speed the transition from sick care to healthful caring. DrJ is the recipient of the Merck, Sharp & Dohm Excellence in Research Award, the J.D. Lane Award, and the U.S.P.H.S. Meritorious Service Award. DrJ was honored as an International Scientist of 2003 by the IBC, Oxford, England, UK for his lifetime contributions to clinical medicine, biochemistry, immunology, methodology, and integrative health policy. DrJ's medical education started in the conventional manner but was introduced to healing modalities that still mostly lie outside of academic Western Medicine largely due to his association with comprehensive practitioners, healers, and spiritual beings. DrJ rediscovered that we all have the power to change our lives, habits, and future, particularly by choosing wisely and comprehensively about what we eat, drink, think, and do. He has formulated a unique enabled path to wellness that helps one thrive rather than just survive through the principles of Nature's pHarmacy™.  For more information, visit his website:  https://www.drrusselljaffe.com/   *****   Cutting Edge Health podcast website: https://cuttingedgehealth.com/   Cutting Edge Health Social and YouTube: 
YouTube channel: youtube.com/@cuttingedgehealthpodcast Instagram - https://instagram.com/cuttingedgehealthpodcast
 Facebook - https://www.facebook.com/Cutting-Edge-Health-Podcast-with-Jane-Rogers-101036902255756   Please note that the information provided in this show is not medical advice, nor should it be taken or applied as a replacement for medical advice. The Cutting Edge Health podcast, its employees, guests and affiliates assume no liability for the application of the information discussed.   Special thanks to Alan and Maria on the Cutting Edge Health team!

The extraterrestrial comedy podcast where we probe a dirty demon that just might be lurking in your bathroom. If you drop a noisy one, this thing might come for you. This creature has been around since before time and has caused chaos through olden times and modern times. In fact, you could say that when s**t goes down, the Šulak will usually be there. If the Šulak slaps you, this could leave a mark not just on your face but on the very function of your brain. Sure, some people may claim that this was just an early explanation for disease related to poor bathroom hygiene, pre-science, but can those same people explain the deaths of many well-known historical figures without Šulak? Science isn't that powerful, folks, but Šulak is. Or are they? Don't ask us about “sweet baby Jesus” because we genuinely have no idea. Keep up your cardio and you should be able to… All that and more on this week's file.     Patreon: https://www.patreon.com/butitwasaliens   Store: https://butitwasaliens.co.uk/shop/     Probe us: Email: butitwasaliens@gmail.com Instagram/Threads @ ButItWasAliens Twitter @ ButItWasAliens Facebook: @ ButItWasAliens - join Extraterrestrial Towers     Music:  Music created via Garageband. Additional music via: https://freepd.com - thank you most kindly good people.     Sources: van de Goot, F. R. W. and ten Berge, R. L. (2001) A demon in the bathroom. Journal of Clinical Pathology. 54 (11). pp. 876 Available online at https://jcp.bmj.com/content/54/11/876 Accessed 19/04/2023   YouTube summary of toilet demons from Religion for Breakfast giving some concise information on ancient toilet difficulties: https://m.youtube.com/watch?v=8OFYKq9pP58

Dr. Zvi Jacob Schreiber completed his medical school at the Medical College of Wisconsin. His residency training for Anatomic and Clinical Pathology was at SUNY Stony Brook, where he was chief Resident.  He completed a Post-Doctoral Fellowship at NY-Presbyterian Hospital Columbia University for Surgical Pathology and GI Pathology. Dr. Schreiber has worked in both academic hospital practice as well as commercial laboratories, and is laboratory director at CDX Diagnostics, an advanced diagnostic platform that leverages artificial intelligence enabled tissue analysis and 3D imaging to reliably detect precancerous cells. He is board certified in anatomic and clinical pathology. _______________________________________________________ Become a JOWMA Member! www.jowma.org  Follow us on Instagram! www.instagram.com/JOWMA_org  Follow us on Twitter! www.twitter.com/JOWMA_med  Follow us on Facebook! https://www.facebook.com/JOWMAorg/ Stay up-to-date with JOWMA news! Sign up for the JOWMA newsletter! https://jowma.us6.list-manage.com/subscribe?u=9b4e9beb287874f9dc7f80289&id=ea3ef44644&mc_cid=dfb442d2a7&mc_eid=e9eee6e41e

This interview is an absolute gem with my friend, Dr. Russell Jaffe, who is a true authority in the field. He's renowned as the brilliant mind behind the ELISA test for heavy metal sensitivities and has an extensive range of fantastic detoxification supplements. Dr. Jaffe is a featured speaker in my upcoming Heavy Docuseries, set to launch on Valentine's Day in 2024. He also just released a remarkable new book, "How to Thrive in the 21st Century," which delves into the world of nutrition and optimizing it for detoxification. In today's podcast, we're diving deep into various topics, from the significance of vitamin C to essential nutrients like magnesium, the top five daily detox foods, and the importance of choline in enhancing magnesium's effects. Dr. Jaffe will enlighten us on how tripling your magnesium intake can revolutionize detox, while benefiting your brain, heart, digestion, and metabolism. We'll also explore how the presence of heavy metals in your body leads to free radicals, diminishing your antioxidant defenses and hastening the aging process. This, in turn, slows down your metabolism, making it easier to gain weight. There's an abundance of valuable insights in this episode, and I can't wait to share it all with you.  On today's podcast, you will learn: Russell Jaffe's protocol for living to 120. The top foods to help your body detox daily. The importance of proper mineralization. The relationship between heavy metal toxicity and disease. How to help reverse diabetes and obesity. Russell Jaffe's approach to diet and cuisine.   About Dr. Russell Jaffe: Dr. Russell Jaffe received his BS, MD and Ph.D. from the Boston University School of Medicine in 1972. He is board certified in Clinical Pathology and in Chemical Pathology. Dr. Jaffe's skeptical view and research of alternative health became a rich educational experience that transformed him into a student of such healing methods as Traditional Chinese Medicine, acupuncture, active meditation, homeopathy, and manipulative arts. He realized the limitations of Western medicine and reinvent himself. Dr. Jaffe collaborated with colleagues to start the Health Studies Collegium, a think tank that focuses on sustainable solutions to global health needs. For the last 30 years, Dr. Jaffe has advocated a system that treats people, not diagnoses; causes, not consequences; and promotes long term sustainable solutions as an alternative to a system dominated by prescriptive, symptom-suppressive solutions. Dr. Jaffe's cumulative experiences enabled him to build PERQUE Integrative Health, a company that offers the world scientifically proven, integrative health solutions that speed the transition from sick care to healthful caring. Dr. Jaffe's practical contributions to clinical medicine and to healthcare policy focus on functional, predictive tests and procedures designed to improve the precision of both diagnosis and of treatment outcomes. He has authored nearly 100 articles on the subject. Dr. Jaffe is the recipient of the Merck, Sharp & Dohm Excellence in Research Award, the J.D. Lane Award, and the U.S.P.H.S. Meritorious Service Award. He teaches and lectures widely on nutritional immunology. For more about Dr. Jaffe, please visit drrusselljaffe.com   ✨SUBSCRIBE✨ http://bit.ly/38pyo1U

On this week's episode, Rich Thayer and Mickey Urdea are exploring metagenomics with Dr. Rick Nolte, an engaging expert on the subject. Dr. Nolte helps to define what metagenomics is, its diagnostic uses, its advantages, and where the field is going. This is a delightfully in-depth interview about a complicated but important topic that is very much worth your time; please enjoy. Frederick (Rick) S. Nolte, PhD, is currently a Senior Director/Medical Advisor at Karius, the microbial cell free DNA company, and Professor Emeritus of the Department of Pathology and Laboratory Medicine at the Medical University of South Carolina. He served as Vice-Chair for Laboratory Medicine/Medical Director of Clinical Laboratories and Molecular Pathology. He is a Diplomate of the American Board of Medical Microbiology and a Fellow of the American Academy of Microbiology. Dr. Nolte completed his B.S. degree in Biology at the University of Cincinnati, and his Ph.D. in Medical Microbiology at the Ohio State University. Dr. Nolte completed a postdoctoral fellowship in Public Health and Medical Laboratory Microbiology at the University of Rochester. Prior to coming to MUSC in 2007, he spent 18 years at Emory University School of Medicine where he was a Professor of Pathology and Laboratory Medicine and Director of the Clinical Microbiology, Molecular Diagnostic, and Serology Laboratories at Emory Medical Laboratories. He is active in and held positions of responsibility in the American Society for Microbiology, Association for Molecular Pathology, Clinical and Laboratory Standards Institute, Infectious Diseases Society of America, American Society for Clinical Pathology, College of American Pathology and American Association for Clinical Chemistry. He has authored numerous book chapters, practice guidelines, and peer-reviewed publications in the areas of clinical microbiology and molecular diagnostics.

Dr. Elli Theel and Dr. Alex McAdam discuss recent viral outbreaks with expert virologists. Recorded before a live audience at ASM Microbe 2023. Topics: What are the recent epidemiologic and diagnostic findings with Mpox?  What are the reservoirs for influenza A H5N1 and how is it transmitted to humans? Why was there such a large number of cases of human metapneumovirus this past respiratory virus season? Guests: Dr. Ben Pinsky, Director of the Clinical Virology laboratory and Professor of Pathology and Medicine at Stanford Health Care and the Stanford University School of Medicine Dr. Ryan Relich, Director of Clinical Microbiology and the Special Pathogens Unit laboratory at IU Health and Eskenazi Health and an Associate Professor of Clinical Pathology and Laboratory Medicine at the Indiana University School of Medicine This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at https://jcm.asm.org and on https://twitter.com/JClinMicro. Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Follow JCM on Twitter via @JClinMicro

In today's VETgirl online veterinary CE podcast, we're joined with Dr. Ashleigh Newman, VMD, DACVP, Assistant Clinical Professor at Cornell University, on the the top tips for your next clin path submission. When we're submitting or running clinical pathology samples, what things are we doing wrong as veterinarians and veterinary technicians? What can we do to optimize the accuracy of results obtained with complete blood counts? What are the most common errors seen with chemistry/biochemistry testing? What are some of your "pet peeves" with cytology submissions, and what makes you happy on your request forms (and can potentially benefit the patient and veterinary team more!)? Learn all you need to know in clin path in this VETgirl podcast!

 In this episode of the Elaborate Topics Podcast, Lona Small interviews Unika Alexander, a medical lab scientist turned entrepreneur. Unika shares her journey from working in the lab to co-founding Proficient Lab, a SaaS platform coupled with consulting services for laboratory training, competency plans, and compliance management. Unika is the co-founder and CEO at The Proficient Lab, a training and competency management software. Her laboratory career has focused on operations and R&D in the IVF and reproductive tissue banking areas. She has a master's degree in biomedical science, from Eastern Virginia Medical School. She is a Clinical Laboratory Scientist licensed by American Society of Clinical Pathology with 12 years of experience in reproductive medicine.Unika's passion for training and competency stemmed from the frustration she experienced in various labs where training was either non-existent or inadequate. Recognizing the crucial role of training and competency in maintaining a quality system and ensuring patient care, Unika embarked on a mission to bridge the gap in the industry. There are a few points Unika brought out about her journey, and lessons we can get from them. Listen to the full episode to learn more. ·      The importance of having a robust training and competency programBy prioritizing training and competency, you create a culture of quality and patient safety, continuous improvement, enable employees to perform at their best, and position your organization for long-term success. ·      The importance of having a mentor who believed in her potential and pushed her to take on more challenging roles.  Finding mentors or coaches who can guide and support you in your journey can be invaluable. They can provide valuable insights, help shape your vision, and offer encouragement along the way. ·      The importance of her being honest, open, and confident about her goals as an entrepreneur. Clearly defining your objectives and being confident in your abilities can help you navigate new paths with purpose and determination. ·      Making the most of her time: Transitioning into new paths often requires balancing various responsibilities. Unika mentions utilizing her subway commutes for strategic thinking.  Finding pockets of time throughout the day and making the most of them for productive activities can help you move forward on your entrepreneurial endeavors. ·      Success is not a linear journey. It often involves overcoming roadblocks and facing challenges.  Embrace the ups and downs, learn from failures, and stay focused on moving forward, one step at a time. Persistence, adaptability, and a growth mindset are key in navigating the entrepreneurial path. Unika left 3 other tips for the audience:1.     Prioritize training and competency. This not only helps with regulatory requirements, but saves money, saves time and saves lives.2.     Believe in yourself. Never think that you don't have the power to speak up. 3.     You belong!Listen to the full episode for  great insights you can apply, to improve yourself and your lab's training and competency goals. You can connect with Unika on LinkedIn at   Unika Alexander, MSc, MLS (ASCP)Contact The Proficient Lab at theproficientlab.com Call to ActionYou can reach Lona Small directly at lonasmall@lonasmall.com  You can also catch Lona on LinkedIn under Lona Gordon Small and follow hashtag #YouAreAnEqualPartOfTheWhole. We would love to feature YOU!!! Share your favorite takeaway from today's episode or anyone from this season: Video Review Be an eLABorate Supporter! 1.       Listen on directimpactbroadcasting.com, Spotify, Apple Podcast, or your favorite podcast platform2.       Become a member of LabVine at labvinelearning.com and listen to eLABorate Topics podcast on VineStream3.       Don't forget to subscribe to the show on your phone, tablet, or notebook so you never miss an episode! 4.       Be sure to leave a comment, and share it with fellow medical laboratory professionals!5.       Join our eLABorate Topics Group on LinkedIn6.       Leave us a Video Review and we will feature you on our Social Media: Video Review

On this episode of The Association Podcast, we welcome Ron Mark Moen, CIO of the American Society for Clinical Pathology. We discuss the role of CIOs in the association market, the qualities that make a good CIO, and how to bridge the gap between technical teams and the business side of an organization. We also get into the challenges of adopting new technology, the importance of empathy and expertise in serving customers, and the importance of feedback, integrity, and transparency in building high-performing teams.

“Without mastering collaborative relationships, both inside and outside the company, we won't produce the outcomes needed....”   — Lori BeerGreat leaders understand the incredible value of collaboration, especially in healthcare. Leadership is a TEAM sport.The World Health Organization defines interdisciplinary teams as “multiple health workers from different professional backgrounds work[ing] together with patients, families, carers (caregivers), and communities to deliver the highest quality of care." So, why are interdisciplinary relationships an important aspect of your role as a leader, when healthcare and clinical care teams are becoming increasingly more specialized?Well....Grab a pen and notepad! In today's essential episode, Melody Boudreaux Nelson and Stephanie Whitehead break down the benefits of establishing relationships with care teams and how these relationships are critical to your success in laboratory management!Special Guest Bio:Melody Boudreaux Nelson received her master's degree in clinical laboratory management from RUSH University in 2019 and has been in laboratory administration roles since 2017. Melody is currently a resident in the Doctor of Clinical Laboratory Science program through the University of Kansas Medical Center. She also sits on the Council of Laboratory Professionals through the American Society for Clinical Pathology. Melody's experience in laboratory leadership includes oversight roles in a core laboratory, operational management, and informatics.Listeners can connect with Melody using:Email: mnelson11@kumc.eduLinkedIn: https://www.linkedin.com/in/melody-nelson-ms-mls-ascp-77b7aa167/Also, for more information check out our previous episodes related to this topic: eLABorate Topics | Episode 8: "Thank you for being a Friend"-The Importance of Work Friends (directimpactbroadcasting.com) eLABorate Topics | Episode 4: "The Power of Social Capital"- Dr. Kami Rapp (directimpactbroadcasting.com) We would love to feature YOU!!! Share your favorite takeaway from today's episode or any of the episodes from this season: Video ReviewConnect with Stephanie WhiteheadTo connect with Stephanie for more on this and other leadership and personal development topics, click on the link above.Be a Professional Mentor:Mentorship Program - ASCLSASCP Mentorship ProgramBe a Supporter! 1.      Join our community! Be sure to follow @eLABorateTopics on LinkedIn. 2.      Listen on directimpactbroadcsting.com, Lab Vine or your favorite podcast platform3.      Don't forget to subscribe to the show on your phone, tablet or notebook so you never miss an episode! 4.      Be sure to leave a comment, and share with a fellow medical laboratory professionals! Be a Guest!If you have a leadership or laboratory message to share and would like to be a guest on the show, please reach out to us at elaboratetopics@directimpactbroadcasting.com or Direct Impact Broadcasting on Social Media.  Please tune in next week to hear another amazing episode of eLABorate Topics!

In this exciting episode, co-host Stephanie Whitehead and Sean Tucker, MBA, MLS (ASCP), discuss their professional journeys as lab leaders. Tune in as Sean shares how his continuous focus on building cultures, encouraging emerging leaders and volunteering in a professional organization has shaped his leadership style. Listeners can learn more about the CLMA and the Body of Knowledge here:Clinical Laboratory Management Association : About CLMASean Tucker is the Director of Laboratory Services at North Kansas City Hospital in Kansas City Missouri. He received his B.S. from the University of Kansas Medical Center in Clinical Laboratory Science and Molecular Biotechnology. Sean received his Masters in Business Administration with Healthcare Emphasis from Rockhurst University. Sean has been an active member of the Clinical Laboratory Management Association on both the local chapter and national level. He currently is the CLMA Chapter representative on the CLMA Advisory Group for the American Society of Clinical Pathology. Sean received the ASCP Forty under 40 award in the 2014 inaugural ceremony and was also awarded the KUMC Early Career Achievement in Health Professions Alumnus by his alma mater in 2017. Sean enjoys cooking, coaching soccer, riding motorcycles and spending time with his wife Angel and two children Payton and Genevieve.Listeners can connect with Sean Tucker on LinkedIn or Twitter.Linkedin: linkedin.com/in/sean-tucker-mls-ascp-mba-42a25610Twitter: @oneworldonelabWe would love to feature YOU!!! Share your favorite takeaway from today's episode or any of the episodes from this season: Video ReviewBe an eLABorate Supporter!  Listen on directimpactbroadcasting.com, Spotify, Apple Podcast, or your favorite podcast platform Don't forget to subscribe to the show on your phone, tablet, or notebook so you never miss an episode!  Be sure to leave a comment, and share it with fellow medical laboratory professionals! Join our eLABorate Topics Group on LinkedIn Leave us a Video Review and we will feature you on our Social Media: Video Review Be a Guest on our show!If you have a leadership or laboratory message to share and would like to be a guest on the show, please reach out to us by completing the guest interest form or send us an e-mail at elaboratetopics@directimpactbroadcasting.com.Please tune in next week to hear another amazing episode!

Data is fundamental to the modern world. From education to healthcare to economic development and public policy, we rely on data to allocate resources and make decisions. In Caroline Criado Perez's groundbreaking book, Invisible Women: Exposing Data Bias in a World Designed for Men, she contends that there's a gender data gap. And because the bulk of the world's data is based on male bodies and behaviors, we live in a world that caters to men and disadvantages women. How does this gender data gap impact women in pathology and laboratory medicine? And what can we do to make the profession more inclusive? On this episode of Inside the Lab, Host Kelly Swails, MT(ASCP), is joined by Dr. Alison Krywanczyk, MD, FASCP, Deputy Medical Examiner at the Cuyahoga County Medical Examiner's Office in Cleveland, Ohio, Dr. Letycia Catalina Nunez-Argote, PhD, MPH, MLS(ASCP)CM, Assistant Professor of Clinical Laboratory Sciences at the University of Kansas Medical Center in Kansas City, Kansas, and Dr. Catherine M. Stefaniuk, DO, MBA, FASCP, Assistant Medical Director of Clinical Pathology at the University of Cincinnati Medical Center, for an ASCP Leadership Institute Book Club discussion of Invisible Women.Dr. Krywanczyk, Dr. Nunez-Argote, and Dr. Stefaniuk discuss the unpaid work many women do and share their experiences with the changing roles of breadwinner and homemaker between the genders. They explore the negative perceptions of women in positions of authority and explain how the myth of meritocracy has impacted their careers in pathology and laboratory medicine. Listen in for insight on designing laboratory spaces for women and learn to leverage your knowledge as a medical professional to advocate for women in the healthcare system.Topics Covered· How the gender data gap in healthcare caters to men and actively disadvantages women· The unpaid work most women do and the changing roles of breadwinner and homemaker between the genders· Why so many women trade flexibility for advancement and how working part-time disadvantages women in terms of healthcare and retirement benefits·  How the gender data gap impacts pathology and laboratory medicine and what we can do to make the laboratory more amenable to women· The negative perceptions of women in positions of authority and how that impacts the way we work·  Situations where our knowledge as medical professionals can help us advocate for women whose symptoms are not understood or believed· How insights gained from Invisible Women will influence decision-making moving forward Connect with ASCPASCPASCP on FacebookASCP on InstagramASCP on TwitterConnect with Dr. KrywanczykDr. Krywanczyk on Twitter Connect with Dr.Nunez-ArgoteDr. Nunez-Argote on TwitterConnect with Dr. Stefaniuk Dr. Stefaniuk on LinkedInResources ASCP Leadership InstituteInvisible Women: Exposing Data Bias in a World Designed for Men by Caroline Criado PerezInside the Lab in the ASCP Store 

In this episode we interview two of the authors of a recent paper, Diagnosis and management of severe congenital protein C deficiency (SCPCD): Communication from the SSC of the ISTH, Dr Maha Othman and Dr Leonardo Brandao on this paper from the Journal of Thrombosis and Haemostasis. 2022;20:1735–1743. Severe congenital protein C deficiency (SCPCD) is rare and there is currently substantial variation in the management of this condition. A joint project by three Scientific and Standardization Committees of the ISTH was developed to review the current evidence and help guide on diagnosis and management of SCPCD.About our guests:Dr. Maha Othman is a clinical pathologist/hematologist with specialized training in haemostasis laboratory testing and molecular genetics of bleeding disorders. She obtained her medical degree and MSc in Clinical Pathology in Mansoura University in Egypt. She then completed her PhD in Pathology from Southampton University, UK. After this, she pursued post-doctoral research training in molecular genetics of hemophilia and von Willebrand disease with Dr. David Lillicrap, at Queen's University, Canada. Dr. Othman is currently a full Professor at the School of Medicine, Queen's University and at St Lawrence College, Kingston, Ontario. Her research interests include the clinical and molecular aspects of von Willebrand disease and platelet disorders particularly PT-VWD, and thromboelastography assessment of coagulopathies in women, pregnancy and cancer. She has more than 100 research papers and her research is recognized internationally. She is an editor for Seminars in Thrombosis and Haemostasis and Research and Practice in Thrombosis and Haemostasis Journals. She is a reviewer for a number of Haemostasis journals and a member of several scientific organizing committees on women's health, and advisory boards for international haemostasis conferences. She is the previous Chairman of the Scientific and Standardization Committee (SSC) on Women's Health Issues in Thrombosis and Haemostasis of the ISTH and currently CO-Chair on the SSC for DIC. She is a passionate educator and mentor and an advocate for rare bleeding disorders and bleeding and clotting disorders in women.Dr. Leonardo Brandão  is a native Brazilian who joined the staff at The Hospital for Sick Children in 2004. Since 2019, he has been the Thrombosis Program director. He obtained his medical degree at the University of São Paulo (USP) School of Medicine (FMUSP) before moving to North America, where he completed his post-graduate training (Paediatrics Residency at Emory University, Atlanta/GA, Paediatric Haematology/Oncology fellowship at St. Jude Children's Research Hospital, Memphis/TN, and a second fellowship in Paediatric Coagulation at Weill Cornell University, New York/NY). After finishing his training, he moved to Canada to focus on the field of paediatric thrombosis at SickKids. He is the past-chair of the thrombosis committee for the Canadian Pediatric Thrombosis Hemostasis Network (CPTHN), past-Canadian representative-elect for the Hemostasis and Thrombosis Research Society (HTRS), past-member of the first paediatric venous thromboembolism panel for the American Society of Hematology (ASH), past-co-chair of the paediatric thrombosis subcommittee for the International Society on Thrombosis and Hemostasis (ISTH), and a member of Thrombosis Canada. Links:Thrombosis Canada Clinical Guide:Support the showhttps://thrombosiscanada.caTake a look at our healthcare professional and patient resources, videos and publications on thrombosis from the expert members of Thrombosis Canada

Christina Nickel is the Director of Clinical Laboratory Services at Bryan Health. She leads a team of professionals who implement, provide and ensure high-quality laboratory and patient testing services across 20 clinics and 4 critical access hospitals. Christina joined Bryan Health in 2008 as a Laboratory Quality Manager. Prior to this, she served as Laboratory Director for Heartland Urgent Care and as a Medical Technologist for Exempla Healthcare, Lincoln Community Hospital and St. Francis Medical Center. Christina earned her Bachelor's degree in Medical Technology from the University of Northern Colorado and her Master's in Healthcare Administration from Bellevue University. She earned her Medical Laboratory Scientist certification through the American Society for Clinical Pathology and is also a Certified Professional in Healthcare Quality through the National Association for Healthcare Quality. Learn more about Christina at https://atchainternational.com/healthcare-and-higher-podcast-ep63-christina-nickel/ For a complete list of guests and links to past episodes, visit https://atchainternational.com/healthcare-and-higher-podcast/ Connect with Iqbal on: - Linked at https://www.linkedin.com/in/iqbalatcha/ - Instagram at https://www.instagram.com/iqbalatcha1 - Twitter at https://twitter.com/IqbalAtcha1 Join us next week for another exciting episode of the "Healthcare and Higher" podcast! #HealthcareAndHigher #IqbalsInterviews Song Credits: "Life Is A Dream" by Michael Ramir C. "Stay With Me" by Michael Ramir C. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/iqbal-atcha/support

Podcast Editor, Tracy Carlson, interviews author William Siska about the article, "Scientific and Regulatory Policy Committee Points to Consider: Integration of Clinical Pathology Data With Anatomic Pathology Data in Nonclinical Toxicology Studies" which can currently be found in  Volume 50, Issue 6 of Toxicologic Pathology. Click here to read the article

Kamran Mirza is an Associate Professor of Pathology and Laboratory Medicine, Medical Education, and Applied Health Sciences at Loyola University Chicago Stritch School of Medicine and Parkinson School of Health Sciences and Public Health in Maywood, Illinois. He serves as the Assistant Dean for Diversity Equity and Inclusion at Stritch School of Medicine, Vice-Chair of Education and Academic Affairs in the Department of Pathology and Laboratory Medicine, Program Director of the Hematopathology fellowship, founding Program Director of the M.S. in Medical Laboratory Science, Assistant Course Director for the M2 Mechanisms of Human Disease Course, the Director of medical student  pathology education in the Department of Pathology and Laboratory Medicine, and a Health Equity advocate for Stritch School of Medicine.Dr. Mirza graduated with academic distinction and as recipient of the "Rivaz Gold Medal" for overall excellence from Aitchison College in Lahore, Pakistan in 1998. He completed medical school at the prestigious, independent, research University - Aga Khan University in Karachi, Pakistan in 2003. He completed his Ph.D. thesis work under Professor Asrar B. Malik, PhD, at the University of Illinois at Chicago in 2010. He continued his training at the University of Chicago, where he completed an AP /CP Pathology residency.   He continued his training at the University of Chicago and received fellowship training in hematopathology (under the supervision of Dr. James Vardiman) and thoracic pathology (under the supervision of Dr. Aliya Husain). Given his passion for medical education, he completed a fellowship in Medical Education Research, Innovation, Teaching & Scholarship (MERITS) at the University of Chicago.An award winning educator and mentor, Dr. Mirza has been the recipient of several dozen local, regional and national teaching awards. He is the recipient of the 2022 Association of Pathology Chairs Michele Raible Award for Distinguished Education. He received the 2021 American Society for Clinical Pathology's H. P. Smith Award for Distinguished Pathology Educator, the 2021 College of American Pathologists Pathology Advancement Award, the 2020 CAP Resident Advocate Award, and the 2019 ASCP Mentorship Award. He received both the regional and national M. Brownell Anderson Award for New and Emerging Educators by the Central Group on Educational Affairs (CGEA), the Midwest education group within the Association of American Medical Colleges (AAMC) in 2020. The American Society of Clinical Pathology recognized him as a Top 5 Forty Under Forty honoree in 2017 and he was a recent faculty inductee to the Alpha Omega Alpha Honor Society via Stritch School of Medicine. Dr. Mirza has been recognized in The Pathologist magazine's Power List 100 consecutively for the past 5 years and he is one of the top 10 most followed Pathologists on Twitter. Dr. Mirza spearheaded the creation of PathElective.com, a free, modular website that has provided pathology education to over 100,000 users across the world in the past year alone. In efforts of advancing pathology, he has also co-founded the ASCP's Virtual Pathology Grand Rounds, the PathPod podcast, the International Collaborative of Pathologists, www.hemereports.com, and the Digital Communications Fellowship in Pathology in partnership with the Pathologist magazine. He is the Chair-Elect for the CGEA and a member of the APC UMEDs council. He serves on the advisory board for "Inside the Match" and "Match to Path" platforms and has been honored with several teaching and education awards at the medical student and resident level and continues to explore novel ways to impart pathology pedagogy across the world. Dr. Mirza's educational research focuses on molecular pathogenesis of myeloid malignancies, novel pedagogical tools in medical education, the advancement of interprofessional education, and use of social media for pathology education.

In this series, PathPod gathers pathologists Around The Scope to discuss their work in depth.  In this episode, we hear from the authors of a Letter to the Editor: Pathology and Abortion Rights Advocacy: Considerations in a Post-Roe World, published in the American Journal of Clinical Pathology (@ajcpjournal). Dr. Mike Arnold (@MArnold_PedPath) speaks with authors Dr. Jeremy Jacobs (@jwjacobs12), Dr. Nicole Jackson (@NicoleJacksonMD), Dr. Anne Mills (@AnneMillsMD), Dr. Elisheva Shanes (@ElishevaShanes), and Dr. Garrett Booth (@DrGSBooth1) about how the end of Roe v. Wade has impacted patient care pathologists provide, from perinatal pathology, cancer diagnosis and treatment, transfusion medicine, to forensic and autopsy pathology.   Featured public domain music: Main Stem by US Army Blues

The emergence of HER2-low therapies for metastatic breast cancer is a paradigm shift in the traditional binary classification of a patient's HER2 status, creating a need for practice changes in pathology necessitated by the expansion in how HER2-low breast cancer needs to be classified and treated. During this recorded 2022 ASCP Annual Meeting session, a moderated expert faculty panel will discuss evolving and emerging trends in breast cancer classification and reporting across the HER2+ spectrum. They will also discuss how pathologists and laboratory professionals can prepare for HER2-low classification, tracking, and reporting. In addition, they will review some of the current challenges in HER2 testing and explore opportunities to prepare for the future landscape of HER classification in breast cancer.  The activity offers 1.0 CME/CMLE credit.  The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.  FacultySwikrity U. Baskota, MDAssistant Professor, Department of Pathology, and Cell BiologyColumbia University Irving Medical Center Marilyn Bui, MD, PhDSenior Member and Professor of PathologyScientific Director of Analytic Microscopy CoreProgram Director of Cytopathology FellowshipMoffitt Cancer Center & Research Institute Mamatha Chivukula, MD, FASCPDirector of Breast Pathology Services and IHC LabMills Peninsula Medical Center, Sutter Health Affiliate Joseph Kim, MD, MBA, MPHPresidentQ Synthesis Credit Designation Statement  The ASCP designates this enduring podcast activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.  ASCP designates this enduring podcast activity for a maximum of 1.0 CMLE credit.  This activity meets CMP and state re-licensure requirements for laboratory personnel.  For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time  Method of Participation  To complete the activity and receive credit, the participant must complete the podcast activity. CME certificates will be provided on-line.  Commercial Support Funded by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.Provided by the American Society for Clinical Pathology in partnership with Q Synthesis.

In the 100 years since its founding in 1922, the American Society for Clinical Pathology has guided the application and evolution of pathology and laboratory medicine. But how much do you know about the history of ASCP? On this episode of Inside the Lab recorded live at the ASCP Annual Meeting in Chicago, our hosts, Ms. Kelly Swails and Dr. Lotte Mulder, are joined by Team Total Kuality, Dr. Kamran Mirza, MD, PhD, Associate Professor of Pathology at Loyola Medicine, and Dr. Theresa Tellier-Castellone, EdD, MPH, MLS(ASCP)CM, Program Director for the School of Medical Technology at Our Lady of Fatima and Rhode Island Hospital; Team Buffy Coat, Dr. Kim Sanford, MD, MASCP, MT(ASCP), Past President of ASCP, and Dr. Will Finn, MD, MASCP, Medical Director at Warde Medical Lab and Past President of ASCP; and Team Diplococcus, Ms. Christy Nickel, MHA, MLS(ASCP)CM, CPHQ, ASCP CMLA Chair and Director of the Clinical Laboratory at Bryan Health, and Ms. Jeannie Guglielmo, MS, MAT, MLS(ASCP)CM, Chair of the Clinical Laboratory Science Program at Stony Brook University, for an enthusiastic game of ASCP Trivia. Our teams answer questions about the ethical issues that concerned ASCP in its early years and the goals of the organization that have remained consistent since its founding in 1922. They buzz in to share their knowledge of how we made history by electing Dr. Emma Sadler Moss as President in 1955. Listen in as the teams compete for bragging rights (and a glow-in-the-dark Erlenmeyer flask). Topics Covered · Dr. Emma Sadler Moss' roles at Charity Hospital in New Orleans and with ASCP in the 1950s· The ethical issues around the practice of pathology that concerned ASCP in its early years· Other professional organizations founded at ASCP meetings· Why ASCP changed its name to the American Society for Clinical Pathology in 2002· How ASCP's Center for Global Health is responding to disasters and expanding laboratory services all over the world· What goals ASCP established when the organization was founded in 1922 (and how those goals have remained consistent in the years since)· How ASCP made history by electing the first female president of a medical organization in 1955 Connect with ASCPASCPASCP on FacebookASCP on InstagramASCP on Twitter Connect with Team Total KualityDr. Mirza on TwitterDr. Tellier-Castellone on TwitterConnect with Team Buffy CoatDr. Sanford on TwitterDr. Finn on Twitter Connect with Team DiplococcusMs. Nickel on LinkedInMs. Guglielmo on LinkedInConnect with Ms. Swails & Dr. MulderMs. Swails on TwitterDr. Mulder on Twitter Resources ASCP Annual MeetingInside the Lab in the ASCP Store 

Rodney Rohde, Texas State University System Regents Professor in the College of Health Professions and chair of the Clinical Laboratory Science Program at Texas State University, joins the Big Ideas TXST podcast to discuss the recent outbreak of monkeypox in the U.S. Rohde holds certifications as a specialist in virology, specialist in microbiology, and molecular biologist from the American Society for Clinical Pathology. He spent a decade as a public health microbiologist and molecular epidemiologist with the Texas Department of State Health Services Bureau of Laboratories and Zoonosis Control Division prior to his academic career. His research interests are diverse but focus on adult education and public health microbiology, specifically with respect to rabies virology, oral rabies wildlife vaccination, antibiotic resistant bacteria and molecular diagnostics/biotechnology. He has published numerous articles and has received a variety of grant support for his research. Rohde is a member in the prestigiousAlpha Mu Tau Fraternity (AMTF) and was named a CLS Distinguished Author, along with his colleagues, in 2013. He received the 2007 ASCLS Scientific Research Award and again in 2014for his work with MRSA and rabies, respectively. Further Reading What is monkeypox? A microbiologist explains what's known about this smallpox cousin What do HIV and COVID-19 have to do with monkeypox? Monkeypox Arrives in the U.S.—Now What? Monkeypox: What We Do and Don't Know About Recent Outbreaks Louis Pasteur's scientific discoveries in the 19th century revolutionized medicine and continue to save the lives of millions today

Hey buddies, I hope everyone is having a great day!! In this episode I speak with Clinical Pathologist and teacher at Purdue Katherine Tate. We discuss veterinary technicians and what their jobs entail. We also discuss the surprising statistic of suicides of that career field. If you dont know anything about Clinical Pathology then stick around and learn with me. Follow me: https://www.instagram.com/more_with_stumpo_podcast/ my Instagram

Dr. Alae Kawam is currently a Surgical Pathology fellow in New York.  She completed Anatomic and Clinical Pathology residency in New York. Originally from NJ, she graduated from New York Institute of Technology College of Osteopathic Medicine in 2018. Prior to that she was a Chemistry major at Drew University and graduated with honors in 2014 and was inducted into Phi Beta Kappa. She serves on the Wellness Committee and the JEDI committee (Justice, equity, diversity, and inclusion) at her current institution. Her professional interests include workplace wellness, DEI, and bias in decision making. Outside of work she enjoys watching comedy, spending time with family, and a good cup of tea.Twitter:  @kawama92

Barbarajean Magnani, PhD, MD, FCAP—Professor of Anatomic and Clinical Pathology, and Medicine, and the former Chair of Pathology and Laboratory Medicine at Tufts University School of Medicine, Boston, MA—is internationally recognized for her expertise in clinical chemistry and toxicology. During her career, she received three Outstanding Speaker Awards from the Association for Clinical Chemistry (AACC); and from the College of American Pathologists (CAP)/CAP Foundation, the 2012 Outstanding Communicator Award, the 2014 Distinguished Patient Care Award, and the 2014 Gene and Jean Herbek Humanitarian Award. Dr. Magnani also received the Distinguished Career in Teaching Award from the Tufts University School of Medicine in 2019.  In addition, she has been named a Top Doctor in Boston magazine and was included by Castle Connelly in Exceptional Women in Medicine. Dr. Magnani was also named one of the Top 100 Most Influential Laboratory Medicine Professionals in the World by The Pathologist. Dr. Magnani—the former Chair of the CAP Toxicology Committee and member of the CAP Council on Scientific Affairs—has served as the member-at-large of the TDM and Toxicology Division of the AACC and as an editor of Clinical and Forensic Toxicology News. Dr. Magnani is also one of the editors of The Clinical Toxicology Laboratory: Contemporary Practice of Poisoning Evaluation, 2nd edition (AACC Press), and Clinical Toxicology Testing: A Guide for Laboratory Professionals, 2nd edition (CAP Press). Her works of fiction include Lily Robinson and the Art of Secret Poisoning (nVision Press), and the Dr. Lily Robinson series, The Queen of All Poisons, The Power of Poison, and A Message in Poison (Encircle Publications).https://www.bjmagnani.com/Be sure to signup for News, Books & Poisons https://mailchi.mp/3621100eb413/news-books-poisons-from-author-bj-magnani Today's episode is brought to you by John's full series of crime thrillers available right now. You can get them through Amazon here: https://www.amazon.com/John-A.-Hoda/e/B00BGPXBMM%3Fref=dbs_a_mng_rwt_scns_share  You can also sign up for the newsletter at http://www.JohnHoda.com to get a free copy of John's new novella Liberty City Nights.Thank you for listening. If you have a moment to spare please leave a rating or comment on Apple Podcasts as that will help us expand the circle around our campfire. If you have any questions please feel to reach out to me via my website http://www.johnhoda.com

Dr. Nicole Alyse Croom (she/hers) is a mixed chick and middle child from Stockton, CA. She received her MD from the University of California, San Francisco; taking a “year off” to get a MPH from the University of California, Berkeley. She stuck around San Francisco to complete Anatomic and Clinical Pathology residency at UCSF before moving to the Pacific Northwest for Forensic Pathology fellowship at the King County Medical Examiner's Office in Seattle, WA. She graduated from her fellowship program in July and is currently taking “time off” performing autopsies per diem with the hopes of joining the local medical examiner's office in Fall 2022. Her forensic-related interests include the association between public health and death investigation, emerging infectious diseases, and educating potential future forensic pathologists through mediums such as “Dead Men Do Tell Tales, "The podcast she co-hosted with colleague. In her spare time, Nicole enjoys reading dystopian fiction, kickboxing, thrifting for dresses with pockets, vicariously living the farm-life through Stardew Valley, and spending an evening at home with a streaming service whilst cuddling with her husband and cat and sipping a craft beer.  Twitter: @nicnac363 Instagram: @everybodydecomposes. 

In this episode, we are joined by Dr. Shiksha Gallow. Dr. Gallow is a South African pioneer in the field of international medical cannabis research. Dr. Gallow holds four degrees in areas such as Biomedicine, & Clinical Pathology. Additionally, she has a Masters in Medical Science, and a master's in Public Health Medicine. She is also the lead investigator for the first medical cannabis trial in South Africa and is an advisor to local and national government and represents part of the Strategic TAT team for medical cannabis Topics: 1. Patient Access in South Africa 2. Medical Cannabis Study in South Africa * Twitter - @TheCannabisRev2 * LinkedIn - @thecannabisreview * Episode Library - https://www.thecannabisreview.ie

Since its inception in 1922, the American Society for Clinical Pathology (ASCP) has worked to provide excellence in education, certification, and advocacy on behalf of patients, pathologists, and laboratory professionals. And while the implementation of these principles has changed dramatically in the last 100 years, the core values of the organization have not. ASCP maintains its patient focus and ongoing commitment to education and standardization. On this episode of Inside the Lab, our hosts, Ms. Kelly Swails and Mr. David Ritter, LMS Business Analyst for eLearning at ASCP, are joined by Dr. Fred Rodriguez, MD, MASCP, FCAP, Emma Moss Professor of Pathology at the LSU School of Medicine and Former President of the American Society for Clinical Pathology, to discuss the history of ASCP. Dr. Rodriguez discusses how and why the organization was founded in 1922, describing ASCP's role at the forefront of developing standards for laboratory practices. He explains how ASCP's Board of Registry Certification became the global gold standard for excellence in laboratory testing and explores the professional organization's efforts to standardize Medical Laboratory Science programs in the last 100 years. Listen in to understand the challenges to advocating for our profession and the critical part pathologists and lab professionals play in modern medicine. Topics Covered · What the field of pathology was like when ASCP was founded in the early 1920s· How and why ASCP was founded as a not-for-profit organization· The 5 objectives articulated in the ASCP constitution (and why they have endured for 100 years)· ASCP's role at the forefront of developing standards for laboratory testing· How ASCP's Board of Registry Certification became the gold standard for excellence in lab testing worldwide· ASCP's efforts to standardize Medical Laboratory Science programs over the last 100 years· What factors contributed to ASCP's growth after World War II · ASCP's role in supporting pathologists in developing countries· How COVID serves as an illustration of the importance of laboratory medicine· Concerns around the proliferation of point-of-care testing and what that means for the laboratory · Advocating for the profession to emphasize our critical role in modern medicine Connect with ASCPASCPASCP on FacebookASCP on InstagramASCP on TwitterEmail podcast@ascp.org Connect with Dr. RodriguezDr. Rodriguez at LSU Health Email fred.rodriguez@ascp.org  Connect with Ms. Swails & Mr. RitterMs. Swails on TwitterMr. Ritter on LinkedIn Resources 'The American Society for Clinical Pathology: The Pathology Society of Firsts' in Laboratory MedicineCenter for Global HealthThe US President's Emergency Plan for AIDS ReliefASCP 2022 Annual MeetingInside the Lab in the ASCP Store 

Today we focus on the academics and data behind COVID-19 and joining us is Dr. Ryan Cole, CEO and Medical Director of Cole Diagnostics, a Anatomic and Clinical Pathology Laboratory. With being 2 plus years into the COVID-19 pandemic, researchers have discovered so much about the virus. Dr. Cole shares his expertise on the importance of UV light, Vitamin D and air circulation to fight against COVID-19. Additionally, we speak about the COVID-19 vaccine and its effectiveness and side effects it has on society. Dr. Ryan ColeDr. Ryan Cole, CEO and Medical Director of Cole Diagnostics, serves clinicians throughout Idaho and the nation with expert pathology diagnoses and patient centered care. Dr. Cole completed his residency in Anatomic and Clinical Pathology at the Mayo Clinic, where he was chief fellow during his surgical pathology fellowship, followed by a year as chief fellow at the Ackerman Academy of Dermatopathology in New York City,under the direction of world renowned dermatopathologist, the late A. Bernard Ackerman. Cole Diagnostics is a full service Anatomic and Clinical pathology laboratory with an extensive menu of testing capabilities, including molecular testing, microbiology, clinical laboratory blood testing, and cytology, in addition to outpatient surgical biopsies. He has helped perform and diagnose over 150,000 Covid tests during the pandemic and has diagnosed 500,000 patients in his career. He has spoken in the Senate and multiple state legislatures, as well as at numerous international conferences, sharing the science and truth about the pandemic. When not focused on science, he enjoys working on his 21 acre organic farm, tending his lambs, cattle, ducks, and chickens, sculpting his 250 tree fruit orchard, saw-milling local urban timberand building one of a kind pieces of furniture, guitars, wood boats and other functional wood art. He is the proud father of 6 daughters he calls his “blonde-tourage."Dr. Cole's Personal SiteGlobal COVID Summit

Dr. Omalu was the first to identify, describe, and name Chronic Traumatic Encephalopathy as a disease entity. Dr. Omalu has testified twice before the United States Congress and has provided hundreds of testimonies as an expert witness in federal courts across the country. Dr. Omalu is a member of the College of American Pathologists, American Society of Clinical Pathology, American College of Physician Executives, American College of Epidemiologists, American Association of Neuropathologists, American Academy of Forensic Sciences, National Association of Medical Examiners, International Academy of Pathology, and the American Medical Association.Dr. Omalu has eight degrees in the medical sciences and business management, including his MB/BS/MD from the University of Nigeria, his MPH from the University of Pittsburgh, and his MBA from Carnegie Mellon University.His work and life have been featured extensively, including a major Hollywood film by Sony Motion Pictures, “Concussion”, and several New York Times best-selling books including “The League of Denial” and “Concussion”.

Anatomic pathology has evolved dramatically in the last 100 years, moving from an entirely subjective practice to a standardized, evidence-based discipline.  Who were the pioneers in developing this modern approach? How have testing processes and laboratory technology changed over time? And what can we learn from the last century of anatomic pathology to help us move the profession forward? On this episode of Inside the Lab, our hosts Ms. Kelly Swails and Dr. Dan Milner are joined by Dr. Sanjay Mukhopadhyay, MD, Director of Pulmonary Pathology at the Cleveland Clinic and Associate Editor of the American Journal of Clinical Pathology, and Dr. William Schreiber, MD, MASCP, Professor in the Department of Pathology and Lab Medicine at the University of British Columbia and Clinical Director of Chemistry at LifeLabs, to discuss the history of pathology and laboratory medicine. Our panelists explain who and what inspired the marked increase in scientific rigor in our profession and explore how the role of the pathologist has changed over time. They speak to how instrumentation has evolved since 1922, describing the diversity of technology in the lab today and the many iterations of molecular testing in surgical pathology and the clinical lab. Listen in for  insight on promoting diversity of thought in pathology and laboratory medicine and get their predictions around the disruptive innovation coming to anatomic pathology in the next 100 years. Topics Covered  · Pioneers in developing modern anatomic pathology's standardized, evidence-based approach· How immunohistochemistry and molecular pathology led to a marked increase in scientific rigor in laboratory medicine· How the role of the pathologist has changed over time to be directly involved in patient care decisions · How instrumentation has changed in the clinical lab over the last 100 years · The diversity of technology in the laboratory today and how automation benefits patients· The evolution of molecular testing in surgical pathology and laboratory medicine and how it's impacted microbiology, genetics and cancer diagnoses· How molecular testing has evolved from conventional cytogenetics to FISH testing to PCR testing (and now to next-generation sequencing)· Where the laboratory has been ahead of the curve on diversity and where we have room for improvement· Dr. Mukhopadhyay's and Dr. Schreiber's predictions around AI and non-invasive diagnostics in future of pathology and laboratory medicine· Transformative vs. disruptive innovation and why anatomic pathology is ripe for disruption Connect with ASCPASCPASCP on FacebookASCP on InstagramASCP on Twitter Connect with Dr. MukhopadhyayDr. Mukhopadhyay on TwitterDr. Mukhopadhyay on LinkedIn Connect with Dr. SchreiberDr. Schreiber at the University of British ColumbiaDr. Schreiber at LifeLabs Connect with Ms. Swails & Dr. MilnerMs. Swails on Twitter Dr. Milner on TwitterResources  Inside the Lab in the ASCP Store 

In today's healthcare environment, laboratory leaders are required to provide the highest quality services to support improved patient outcomes. To succeed, they must implement scalable medical, analytical, and operational strategies, all while driving and balancing fiscal excellence and responsibility. In this episode, host Dr Pat Alagia, senior medical director for Women's and Reproductive Health at Quest Diagnostics welcomes Dr Patrick Mason and Tammy Germini to discuss: Laboratory state-of-the-art programs and processes designed to improve quality, efficiency, and significant cost improvement outcomes Requirements within the lab to help to achieve the successful convergence between medicine and operations, resulting in scalability of the highest performing tests The overall value of laboratory medicine in modern healthcare   About our guests Patrick Mason, MD, PhD, is regional medical director of the Quest Diagnostics Nichols Institute in Chantilly, VA. Dr Mason received his undergraduate, a PhD in Biochemistry, and Doctor of Medicine training at Virginia Commonwealth University. He completed his pediatric residency and endocrinology fellowship at Emory University. Dr Mason remained on the Emory faculty for several years until moving to Inova Fairfax Hospital for Children in 2001. While at Inova, he held a variety of positions, including staff pediatric endocrinologist and director of pediatric research. He held positions as assistant clinical professor of pediatrics at both Virginia Commonwealth University and the University of Virginia and was appointed as special volunteer faculty at Development Endocrinology Branch, National Institute of Child Health and Development, and National Institutes of Health (NIH). Dr Mason joined the Quest Diagnostics Nichols Institute in March 2011 and served as the medical director of endocrinology until April 2015 when he became the medical director of the Chantilly laboratory.   Tammy Germini, MBA, MT(ASCP), is the executive director of operations for health systems at Quest Diagnostics where she oversees the implementation of key strategies aimed to balance operational excellence and financial responsibility. After earning a Bachelor of Science in Medical Technology from the University of North Carolina, Greensboro, she attended the Moses H. Cone School of Medical Technology and was certified by the Board of Certification of the American Society for Clinical Pathology in July 1995. She received her Master's in Business Administration from the University of Scranton in August 2017. Tammy worked for Spectrum Laboratory Network for 15 years as a medical technologist, supervisor, and remote site manager. She then progressed in her career to Geisinger Medical Center where she led the laboratory for 11 years as the director of laboratory excellence and operations director for clinical pathology. Her tenure at Geisinger included oversight of the operations and financial performance for 6 nonprofit hospital laboratories, including the core laboratory for a large health system producing more than 10 million tests per year. Some of her key achievements include participation in the design and transition to a new 115,000 square foot state-of-the-art laboratory building in 2015, successful mergers/acquisitions of 5 hospital laboratories, and successful consolidation of operations into a core lab model. ------------------------------ Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve healthcare management. Quest Diagnostics annually serves 1 in 3 adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. More information is available at www.QuestDiagnostics.com

We've received a lot of great advice from friends and family as we prep to welcome our first baby! One of our friends told us about cord blood storage - something we knew nothing about. After looking into it, we decided to hop on a chat with Dr. Jaime Shamonki, Chief Medical Officer at Cord Blood Registry, to talk all about the science and the why behind collecting and storing our baby's cord blood and tissue. Dr. Jaime Shamonki is a mom of two. She trained in Anatomic and Clinical Pathology at New York Presbyterian Hospital – Weill Cornell Medical College and has completed fellowships at Weill Cornell as well as the University of California, Los Angeles. Prior to joining Generate Life Sciences, Dr. Shamonki developed expertise in women's health and clinical laboratory medicine, serving as the Director of Breast Pathology and Blood Bank Medical Director at Saint John's Health Center in Santa Monica, CA, and as an Assistant Professor at the John Wayne Cancer Institute. Connect with Dr. Jaimie ShamonkiIG:@ShamonkiMDhttps://www.instagram.com/shamonkimd/@CordBloodRegistryhttps://www.instagram.com/cordbloodregistry/Use promo code HOME for over 50% savings on cord blood and cord tissue bundle with 1st year of storage. https://www.cordblood.comTHANK YOU TO OUR FRIENDS AT ADT for making it possible for us to share these stories in a safe and secure place, At Home. https://www.adt.com/AtHomeText 310-496-8667 with your questions for #AtHomePodcast !If you've enjoyed this podcast, please subscribe, rate and share with a friend! Thank you for being a part of the At Home community! Connect with Linda & Drew: instagram.com/athomeinstagram.com/imlindorkinstagram.com/mrdrewscott#AtHome PodcastTHEME SONG BY: Victoria Shawwww.instagram.com/VictoriaShawMusic Chad Carlsonwww.instagram.com/ChadCarlsonMusic MUSIC COMPOSED AND PRODUCED BY:Rick Russohttps://www.instagram.com/rickrussomusicSpecial thanks to all our At Home homies: PRODUCERS:Brandon AngelenoHanna PhanPOST AUDIO ENGINEER:Chris CobainNicole SchacterWEBSITE:Wesley FriendSERIES PHOTOGRAPHER: Dennys Ilicwww.instagram.com/dennydennSponsored by:ADT: It's important to have not just a beautiful home -- but a smart and safer home.https://www.adt.com/AtHomeSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Stanford's Benjamin Pinsky on the potential for even more transmissible and pathogenic versions of the SARS-CoV-2 virus to arise. This podcast is intended for US healthcare professionals only. To read a full transcript of this episode or to comment please visit: https://www.medscape.com/features/public/machine Eric J. Topol, MD, Director, Scripps Translational Science Institute; Professor of Molecular Medicine, The Scripps Research Institute, La Jolla, California; Editor-in-Chief, Medscape Abraham Verghese, MD, Physician, author, and educator; Professor and Vice Chair, Theory & Practice of Medicine, Department of Medicine, Stanford University, Stanford, California Benjamin Pinsky, MD, PhD, Associate Professor, Department of Medicine and Pathology, Stanford University School of Medicine; Director, Clinical Virology Laboratory; Associate Director, Clinical Pathology for COVID-19 Testing, Stanford Health Care, Stanford Children's Health, Stanford, California You may also like: Medscape's Chief Cardiology Correspondent Dr John M. Mandrola's This Week In Cardiology https://www.medscape.com/twic Discussions on topics at the core of cardiology and the practice of medicine with Dr Robert A. Harrington and guests on The Bob Harrington Show https://www.medscape.com/author/bob-harrington For questions or feedback, please email: news@medscape.net

"Its All About The Journey" with triple board-certified, Harvard-trained Dermatopathologist & Founder of GFaceMD and Soyier Skin Collection, Gretchen Frieling, MD.“Dr.G” comes from an extensive background in Anatomic and Clinical Pathology & Dermatology, but 5 years ago, she turned her unique perspective as a skin expert into a wildly successful Aesthetic Practice and secured her spot as an industry leader and educator. She's well known for her innate ability to educate on the pathology of injectables, something she stayed away from early on when marketing her Practice. Fast-forward years later, and she's constantly asked to lecture on industry podiums, contribute to national magazines, and share her perspective on various media outlets. Her expertise as an Injector is closely rivaled by her success as an entrepreneur. From a one-room location at a hair salon to one of the most sought after practices in the Northeast, she's become a master at branding, exceeding Patient expectations, growing a stellar team, and she's earned her stripes as a savvy businesswoman. In addition to her role at GFace, she's also the mastermind behind skincare brand, Soyier, where she's played a major role in formulating each product, designing the packaging, and creating the entire brand presence.Right before the pandemic, she launched FaceITVirtual, and three meetings later, she's put her Midas touch on an international, virtual conference that continues to grow year after year.

Dr. Brian Adkins is the Medical Director of Transfusion and Tissue Service at Children's Health Dallas and an Assistant Professor of Pathology at University of Texas Southwestern. He is board-certified in Anatomic Pathology and Clinical Pathology with subspecialty certification in Blood Banking/Transfusion Medicine and Hematopathology. Dr. Adkins has published multiple papers about Transgender health and was an invited speaker at the 2021 American Society for Clinical Pathology meeting to present on contemporary transfusion and cellular therapy in Transgender and Non-binary individuals Twitter:  Brian Adkins (@path_brian) / Twitter

One important challenge that ASCP is taking on is the notion of visibility of the laboratory.  What do successful clinical pathology lab directors do to bring the laboratory ‘out of the basement' and advocate for the profession with colleagues, hospital leadership and the public at large? And what skills do they lean on to manage their labs successfully and achieve a healthy work-life balance? On this episode of Inside the Lab, our hosts Dr. Dan Milner and Ms. Kelly Swails are joined by Dr. Sarah Riley, PhD, DABCC, FACB, Clinical Chemist, Toxicologist, and Director of the Forensic Toxicology Laboratory at the Saint Louis University School of Medicine, Dr. Ramy Arnaout, MD, PhD, Clinical Microbiologist, Clinical Informaticist, Computational Immunologist, and Associate Director of Clinical Microbiology Laboratories at Beth Israel Deaconess Medical Center, and Dr. Nicole Pecora, MD, PhD, Medical Microbiologist and Associate Director of Clinical Microbiology at Brigham and Women's Hospital, who share their life hacks for clinical pathology. Our panelists discuss what we can do to increase the visibility of the CP laboratory. They address the informatics and business skills that aren't emphasized enough in clinical pathology training and explain how they engage with colleagues to manage their respective labs successfully. Listen in forinsight on setting boundaries based on what's really important to you to achieve work-life balance. Topics Covered · How to increase the visibility of the clinical pathology lab with colleagues, hospital administrators and the general public· Our panelists' thoughts on diagnostic management teams and the benefits to the clinical team of going on rounds  · Why networking is essential to becoming a ‘member of the community' as clinical pathologists· How forming communities of practice and developing an elevator speech can help us get a ‘seat at the table'· Why every clinical pathologist needs to be an ambassador for the profession and how to advocate for CP with hospital leadership· The informatics and business skills that aren't emphasized enough in clinical pathology training· Insight on achieving work-life balance by separating your personal and professional lifeConnect with ASCPASCPASCP on FacebookASCP on InstagramASCP on Twitter Connect with Dr. RileyDr. Riley at Saint Louis University Dr. Riley on Twitter Connect with Dr. ArnaoutDr. Arnaout at Beth Israel Deaconess Medical Center Dr. Arnaout on LinkedIn Connect with Dr. PecoraDr. Pecora at Brigham and Women's HospitalDr. Pecora on LinkedIn Connect with Dr. Milner & Ms. SwailsDr. Milner on Twitter Ms. Swails on Twitter Resources Inside the Lab in the ASCP Store 

Caffeinators, it's time to talk Clinical Pathology! As you're well aware, we want to talk to a representative of each VTS academy to talk about all the cool things technicians do in that specialty. We reached out to the Academy of Veterinary Clinical Pathology Technicians (AVCPT) and got in touch with Lori Balliet, CVT, VTS(Clin Path) to talk about all things clan path! This was a fascinating conversation centered around the work she did in designing the hospital laboratory she manages for a 40+ DVM practice, being the SECOND credentialed technician to have gained this VTS, and so much more about working in a lab. A lot of veterinary technicians do a lot of clinical pathology, and it's wonderful to hear from those that are making a career of doing just that! We think you'll really enjoy this one!   Show Links: Follow us on Facebook: https://www.facebook.com/vettechcafe Follow us on Instagram: https://www.instagram.com/vettechcafepodcast Like and Subscribe on YouTube: https://www.youtube.com/channel/UCMDTKdfOaqSW0Mv3Uoi33qg  Our website: https://www.vettechcafe.com/ Vet Tech Cafe Merch: https://www.vettechcafe.com/merch If you would like to help us cover our podcast expenses, we'd appreciate any support you give through Patreon. We do this podcast and our YouTube channel content to support the veterinary technicians out there and do not expect anything in return! We thank you for all you do.

Dr. Bhanote is a quintuple board-certified physician and published author with expertise in Integrative Medicine and Anatomic & Clinical Pathology, Cytopathology, and Culinary Medicine. Dr. Bhanote has additional training and certifications in Mindfulness-Based Stress Reduction, Plant-Based Nutrition, Ayurveda, Yoga for Cancer Recovery, and as a Yoga Medicine Therapeutic Specialist where she applies a whole-body approach to healing.

Many people have heard about the risk of your BRAIN on drugs, but what about your SKIN on drugs? Your skin, your epidermis is the largest organ of your body and is about 20 square feet. Dr. Antley is a dermatopathologist and talks to High Truth about whether marijuana products can help acne or harmful to the skin. Catherine Antley, M.D. Catherine Antley, M.D. graduated from the University of North Carolina School of Medicine, completed her residency in anatomic and clinical pathology at Duke University Medical Center and fellowship in dermatopathology at the University of Arkansas for Medical Sciences.  She is board certified in Anatomic and Clinical Pathology and in Dermatopathology and is a Fellow of the American Society of Dermatopathology. For 20 years she has served as laboratory director of Vermont Dermatopathology, a woman owned, independent dermatopathology lab serving VT, NY, and NH.  She has a strong interest in public health and prevention and exploring the impact of policy on addiction and health care costs. She has co-authored a number of Vermont Medical Society resolutions on cannabis and recently organized and led a delegation of 10 Vermonters to Iceland to learn about their 20 year history bringing down the country’s high addiction rates using their successful, science based prevention model. She recently contributed a chapter “Cannabis in Dermatology” to the textbook “Cannabis in Medicine, an Evidence Based Approach” edited by Dr. Ken Finn and published by Springer Nature. Cannabis in Medicine: An Evidence Based Review